Carl Leitner, Ph.D.  is a Technical Officer with the World Health Organization, Geneva. He is the former Technical Director of Digital Square at PATH and Associate Director of Health Workforce Informatics at IntraHealth. Carl Leitner brings more than twenty years of experience in informatics, information technology, software development, and education including more than fourteen years of designing and adapting health information systems in low- and middle-income countries.   Leitner has worked closely, in a variety of roles, with many digital health global goods. Leitner also regularly engages with health informatics standards development organization and has co-authored several health informatics standards. Leitner has led numerous workshops working with in-country teams to build their capacity to implement and manage interoperable health information systems and to make use of data for effective decisions and policymaking.

Nicholas Kelley is the Director Data Science & A.I. Innovation in the central Novartis Data & AI organization, and has two main priorities.  First, to identify, prioritise, and launch key use-cases for the AI Innovation Lab in line with its mission of delivering reusable AI capabilities for the scientific and medical core of the business.  Second, on a broader enterprise perspective, to better define the AI opportunities landscape across the value chain.  Here the key focus is on continued improvement of our Novartis data science foundation through innovative partnerships and by leading the data science community and capability building initiatives.

Recent initiatives include seeding and driving AI solutions such as Generative Chemistry as part of the partnership with Microsoft Research, the first cross-Novartis Data Science challenge in collaboration with MIT, and launching the AI for Life Residency program.

Nick has a formal background in computational methodology with a Ph.D. in Biophysics from Stanford University, with career experience in computational biology, chem- and bioinformatics, and most recently in the application of A.I. and machine learning in health. 

Since 2014, Dr. iur., LLM, Lukas Engelberger is a member of the Government of the Canton Basel-Stadt and Head of the Public Health Department. 

He is also President of the Swiss Conference of the Cantonal Ministers of Public Health (GDK) and Member of the Board of Swissmedic (Swiss Agency for Therapeutic Products). He also is Member of the Board of Cantosana AG.

After his studies in law at the universities of Basel, Fribourg and Bern, he obtained the bar examination (Canton of Basel-Stadt) in 2001. In 2003 he doctorate in law at the university of Basel and holds a LLM (University College London). 

From 2003-2005 he was practising as an atorney at Bär & Karrer in Zürich (Practice areas: M&A, capital markets, general corporate and commercial matters). From 2005- 2014 Mr. Engelberger was a legal counsel at F.Hoffmann-La Roche Ltd. in Basel.

Elena Bonfiglioli is Microsoft’s Global Business Leader for Healthcare and Strategy Lead for Pharma Life Sciences. 

In this capacity she is responsible for industry pharma strategy and commercial go-to-market, enabling co-innovation and engagement with strategic customers and partners to accelerate their transformation with cloud and AI.  

She was recently elected as Vice Chair of the DIGITALEUROPE Executive Council for Healthcare. 

A signature outcome of her work – together with a core team across engineering and research – was the design and launch of the AI partnership with Novartis in 2019 and the AI for Leprosy initiative with Novartis Foundation and Fiocruz, recently published in The Lancet/Elsevier.  

Elena co-chaired the Health Cloud Council for Microsoft and partners from 2015-2019 where she led the development of a position on secondary use of health data and championed the work on data collaboratives, leading to the creation of the first global data collaborative in cardiovascular population health.

Elena has been working in the health sector for 18+ years, first in health policy at EU level and then as regional business leader in public healthcare across EMEA. In July 2017, Elena was elected to the HIMSS Europe Governing Council.  In 2020 she was nominated one of the top 50 AI Innovators by Intelligent Health.  Elena is one of the founding members of the Holomedicine Association.

She is an active advocate and public speaker, invited to represent the approach of Microsoft for Healthcare and AI and how Data save Lives.  She is also a champion for the transformational impact of meditation in personal and professional development, working with the Centre for Evolutionary Learning; and the empowerment of women in leadership. 

Recent articles:

• (99+) Empowering change: how mixed reality is driving the future of medicine | LinkedIn
• Launching AI4BetterHearts, the First Global Data Collaborative for Improving Cardiovascular Health | Novartis Foundation
• Harnessing health data for better outcomes: a call to action – Microsoft Industry Blogs
• Improving the pace of vaccine distribution through technology – Microsoft Industry Blogs

Vicky Levy is the Deloitte Global Life Sciences sector leader. In this role, she ensures our leaders around the world are able to bring the best of Deloitte to bear in the life sciences sector, helps to build the global capabilities of Deloitte in the sector and guides and advises Deloitte Life Sciences leaders across our global network as they serve global clients. Vicky brings more than 25 years of global life sciences professional services experience to our clients around the globe. She advises executives across a range of topics, including executive transitions, enterprise transformation, commercial performance, culture and diversity, equity, and inclusion.

Dr. Yaron Ilan is the Director of the Department of Medicine at the Hebrew University-Hadassah Medical Center. Dr. Ilan served as the Vice Dean of the Hebrew University-Hadassah Medical School. Dr. Ilan was a Visiting Professor at Harvard University, working on novel immunotherapies. Dr. Ilan’s main areas of research are developing artificial intelligence-based algorithms for improving care, developing immunomodulatory therapies for fatty liver disease, diabetes, and inflammatory bowel diseases, and developing drugs for primary liver cancer. Dr. Ilan holds over 50 patents for discoveries based on his innovative research and has authored more than 300 articles. He is the inventor of several drugs and medical devices developed by several pharmaceutical companies. Several of his innovations have already reached the clinical market. Dr. Ilan is the founder of several companies and is a medical director and advisor for several biotech companies.

A board-certified internist, Daniel Knecht, M.D., currently serves as Vice President, Chief Clinical Innovation Officer, CVS Caremark. Dr. Knecht’s focus is on helping clients better understand the evolving clinical landscape of specialty medications, develop strategies for better patient care and outcomes, and manage costs. 

Prior to this role, as Vice President, Clinical Product, Dr. Knecht was responsible for clinical product ideation, concept development and testing, optimization, launch, performance, and measurement in collaboration with key stakeholders across the enterprise.

Dr. Knecht is a Fulbright scholar and graduated with honors from Dartmouth College. He also has a joint M.D., M.B.A., from Weill Cornell Medical College and Johnson Graduate School of Management where he was a recipient of the Lee Family Scholarship. He is an associate clinical professor at Mount Sinai West in New York City where he still sees patients, and a member of the Board of the Foundation of CUNY School of Public Health.

Dr Stefan Germann is the CEO of Fondation Botnar, a Swiss-based foundation which champions the use of AI and digital technology to improve the wellbeing of young people in urban environments. To achieve this, the foundation supports research, catalyses diverse partners, and invests in scalable solutions around the world.

Dr Germann has spent over 25 years working in various leadership roles in Africa and Asia, focusing on health-related development for children, relief and advocacy work. He was previously the Senior Director of World Vision’s International Sustainable Health Partnership, Innovation and Accountability unit based in Malaysia. His work focused on a complex relief and reconstruction program in response to the Asian Tsunami. 

He has previously held several board and advisory board memberships. These include for the Partnership for Maternal, Newborn and Child Health (PMNCH), UBS Optimus Foundation, REPSSI in Africa, the Global Health Program and The Graduate Institute in Geneva, where he focused on the role of NGOs in global health diplomacy.

Dr Imran Siddiqui studied in London and trained in clinical radiology in the NHS, prior to joining Bayer, where he now leads the Radiology Medical Affairs team for the UK. He focuses on growing value and expertise for both pharmaceutical and medical device products, advising on medical and commercial strategy and driving regulatory excellence and innovation. Imran is passionate about medical education as well as the safe and sustainable adoption of AI technologies. He was a core team member for the global launch of an AI platform technology for medical imaging, was recently awarded a scholarship to complete the renowned UCL ‘Artificial Intelligence in Business’ executive course on AI implementation and strategic business models and sits on the British Institute of Radiology’s AI & Innovation specialist interest group.

Dr. Jim Ritchie is the Chief Clinical Information Officer and Deputy Director for Research and Innovation (Digital Health and Artificial Intelligence) at the Northern Care Alliance and an Honorary Clinical Lecturer at the University of Manchester. He continues to practice clinical medicine as nephrologist Salford Royal, one of the most digitally mature trusts in the NHS.

Jim supported delivery of the Salford Global Digital Exemplar programme, provides clinical leadership to the digital ‘Living Lab’, and has skills and knowledge in design thinking, system evaluation and developing collaborative partnerships with industry. In 2018, he graduated as part of Cohort 1 of the NHS Digital Academy

Over recent years, Jim has led the design and development of the NCA Digital Control Centre Programme; a transformational partnership that will embed advanced technologies and behaviours to optimise operational efficiency and improve care delivery. In addition, he has worked with colleagues to develop partnerships that can deliver new models of care for chronic disease into the NHS. This work includes development of the RevOCE programme which has delivered tools for population risk segmentation, targeted care and holistic multimorbidity clinics.

Natasha Sunderji is the Global Health Lead of Accenture’s social impact business, and also co-leads Accenture’s Health Equity Center of Excellence. She has 18+ years of experience advising companies, NGOs, donors, and multilaterals on social business model design, digital health, and cross-sectoral partnerships. She has designed patient centric solutions with leading health actors, developed 30+ inclusive businesses, and advised policy makers on the investments needed to create robust digital health ecosystems. She was named a World Summit AI Top 50 Innovator in 2020. Natasha holds a Bachelor’s in Biomedical Engineering from University of Toronto, and a Master’s in Public Policy from Harvard Kennedy School.

Elif is the Head of Computational Biology and Exploratory Analytics Products at Roche. She leads a global team of product managers that focus on building bioinformatics, omics and predictive analytics products that enable new hypothesis creation using state-of-the-art, interpretable and robust machine learning and advanced mathematical modeling approaches. 

Elif holds a BS and MS in Chemical Engineering from Bogazici University and a PhD in Structural Biology from Purdue University, where she used molecular dynamics simulations to study the Src kinase activation mechanism. She then joined the Chemical Engineering Department at Bogazici University as a faculty member. Her research spanned both experimental and computational studies on elucidating protein – compound interaction mechanisms and structure based drug design for proteins related to antimicrobial resistance and sphingolipid binding. She moved from >15 years in academia to industry when she joined Roche as the Head of Data Science in Go-to-market Data and Analytics in 2020. 

Valentina is a Partner in McKinsey’s Zurich office. Since joining in 2006, she has worked with multiple Healthcare and Life Sciences stakeholders, including Pharma companies, Health Tech start-ups, Hospitals and NGOs on a range of including how they can leverage advanced analytics to step-change their performance and operating model.

Valentina has been co-leading the QuantumBlack hub in Zurich since 2020, and it’s Digital and Analytics effort in Global Public Health. Valentina is passionate about the topic of diversity and leads Women Recruiting for the Swiss office as well as D&I for the Life Sciences Practice.

Peter Hackel leads the Data Products Team for Takeda’s Global Manufacturing Supply and Global Quality Organization. With his team he builds an environment where data analytics is possible and scalable across the organizational levels and pillars.

He brings more than 14 years of experience in the pharmaceutical industry working in areas such as process development, process optimization, technology deployment and data strategy. He believes the harnessing of technologies such as natural language processing or machine learning built on a sustainable data infrastructure is a differentiating factor in how companies can run operation and serve patients around the world.

Medical radiologist, enthusiast of health innovation with clinical experience in public and private health systems in Latin America and Europe. Since 2020 he has been working at Bayer Radiology.

Mr. Marco Obiso is the Head of the Cybersecurity division and currently acting as Chief of the Digital Network Society Department in the Telecommunication Development Bureau of the International Telecommunication Union (ITU), the lead UN-specialized agency for Information and Communication Technologies (ICT).

He has been working in the ICT field for the past two decades, operating in several ICT-related domains such as network infrastructure development, system integration, application cooperation, IT Service Management, Internet governance and information security.

As Head of the Cybersecurity division, he is currently facilitating the work of ITU in elaborating Cybersecurity strategies and implementing programmes and initiatives as well as leading the ITU’s efforts on enabling the use of ICT applications, for the benefit of ITU Member States, including providing technical assistance in establishing capabilities and working to strengthen coordination and cooperation within the UN system.

Sarah Porter has launched 21 b2b and b2c technology products in 11 countries since 1996 and has a renowned reputation for taking ideas from concept to market with subsequent significant growth globally. 

Emerging tech / AI / Medtech / Singularity / existentialism is where her core experience lies and she has over 20 years of commercial experience.

As a board executive for i2i events (parent company The Guardian Media Group / Apax – Ascential – previously Top Right Group) with the specific remit to rapidly grow the business whilst leveraging operational costs and prepare pre IPO. She sat on the i2i mergers and acquisitions committee identifying, analysing and approaching target businesses and accelerated growth by 22% within 12 months.

Achievements include the launch and acquisition of Money2020 – a leading fintech product. This included negotiation, 3 stage due diligence, its subsequent integration, and the long term geo-adaption into a global portfolio worth over $40m. The launch of World Retail Congress in 10 countries, the re-launch of Cannes Lions festival.

Sarah is a regular keynote speaker on start-ups, business and women / equality related issues and is an ambassador for the Royal Marsden where she champions the use of AI tech in oncology advances.

Giuseppe Marco Randazzo is a cheminformatic data scientist with more than 10+ experience in drug discovery. After completing his Ph.D. in chemical science at the laboratory of chemometrics and cheminformatic University of Perugia, in 2013 moved to the pharmaceutical sciences department of the University of Geneva for a post-doc position in the analytical chemistry group. He worked on machine-learning (ML)/cheminformatics tools for automatic compound annotation in metabolomics approaches. He also worked in a joint venture between the University of Geneva and a private industrial partner, Firmenich, delivering new active nature-identical compounds using ML and cheminformatics approaches. In 2017 he joined the Dalle Molle Institute for Artificial Intelligence in Lugano, developing new AI tools for drug discovery. In 2019 he joined F. Hoffmann-La Roche as a post-doc scientist to implement new machine-learning and AI methods for polypharmacology. In 2021 he joined Endogena Therapeutics in the role of Head of AI and Cheminformatics. He is an enthusiast and active open-source supporter, contributing to several scientific projects.

Patricia Gee leads Deloitte’s Future of Health initiative in Switzerland. She has spent over20 years in the life science and health industry, bringing together cross-sector experience in biopharma, payer, provider and capital markets. She focuses on driving sustainable value, growth and innovation for leading life science clients in the areas of commercial transformation, digital innovation, product launch, marketing, sales and market access.

Dr Andrew Soltan is an NIHR-funded practicing Clinician at Oxford University Hospitals NHS Trust, and Clinical Machine Learning Researcher at the University of Oxford. His research applies machine learning methods to Electronic Health Record data for rapid diagnosis and prognostication in acute and emergency care settings. During the COVID-19 pandemic, Dr Soltan led the CURIAL programme which developed and deployed an AI test to screen patients for infection in Emergency Departments, using clinical data routinely available within 1h. The CURIAL evidence base has achieved two publications in The Lancet Digital Health, showing a 26% reduction in time-to-result when piloted at the John Radcliffe Hospital and reduction in missed COVID-19 cases compared to Lateral Flow Testing alone.
Previously Dr Soltan has worked in industry as Medical Officer at Visulytix, which partnered with Orbis International to make its AI tool for detecting treatable eye disease accessible to doctors in low-resource countries. Since graduating with Distinction in Medicine from the University of Cambridge, Dr Soltan has received awards including an NIHR Academic Clinical Fellowship and a Translational Research award funded by the Wellcome Trust.

Sabina Magalini is a Surgeon of the Emergency and Trauma Surgery Department of the Policlinico Gemelli of Rome Italy (World’s Best Hospitals 2022, Newsweek) and an aggregate Professor of the Catholic University School of Medicine. 

Aside from clinical work she is interested in the organization of emergency medicine and surgery procedures in situations of disaster medicine. Together with her team she has participated in many EU projects dealing with CBRNe response (EDEN, ENCIRCLE, SMARTSTADIUM), decision support systems for first responders (FR) (PULSE, IMPRESS), development of new technologies for FR (NIGHTINGALE), security problems for communication during the pandemic (REACT2, COVINFORM), data sharing for research in medicine (TRUSTEE). 

The increasing importance of cybersecurity for hospital resilience has pushed her interests in the direction of identifying response and responsibilities of hospital personnel. She has coordinated the PANACEA project on people-centric hospital cyber resilience and will be part of the DYNAMO project on business continuity during cyberattacks. 

Partner in the EU Coordination Supporting Action Networks NO-FEAR, INCLUDING, EU-HYBNET, her main effort is in participation of medical personnel as end-users in technological projects in the medical security setting, because this interaction will guarantee the development of the best technology in an EU perspective.

Dr. Felice Burn is an AI innovation expert, medical doctor, clinical researcher and leader of an AI and Data Science CoE at Cantonal Hospital Aarau in Switzerland. With more than 20 years healthcare experience and more than 10 years’ experience in development and integration of artificial intelligence he designed and implemented new AI strategies and AI Governances, has extensive experience in digitalization, big data projects and AI driven solutions to support and optimize healthcare processes to gain important business values for healthcare institutions.

Jacques Gilbert is the Senior Director of Healthcare Strategy at Nuance Communications. Jacques leads business development, strategic partnerships and M&A activities for Nuance’s Diagnostics business unit which includes a large portfolio of AI applications integrated into both clinical and administrative workflows for healthcare providers, pharmaceutical, payors and self-insurance employers and medTech customers. Prior to joining Nuance in 2017, Jacques cofounded start-ups in AI/ML and strategy consulting in financial services sector and more recently held multiple leadership roles in strategic marketing for GE Healthcare. He received Bachelor of Commerce degrees from University of the Witwatersrand in Johannesburg, South Africa

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday.

Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

Nishant Sinha is a Director in Analytics and Strategy, with expertise in Artificial Intelligence, Intelligent Automation, Machine Learning and Analytics Strategy. With around 20 years of consulting in Lifesciences and Financial Services, he brings experience from leading multiple large scale global engagements focused on data driven enterprise enablement and transformation.

He is passionate about Artificial Intelligence, Data and the transformational influence they bring to Business Processes and Business Models. Working with clients across the globe, Nishant takes a customer centric approach to the process redesign enabled by Artificial Intelligence, supporting his clients to drive data driven transformations.

Richard Plumb is a seasoned cyber and physical security speaker. After spending 15 years in the Police, he transitioned to cybersecurity consulting and threat intelligence. He now works as the Cyber Threat Intelligence Lead for NHS Digital, whose team provide cutting edge threat intelligence to the whole of the NHS, from senior leadership teams to the technical teams on the ground. Richard has extensive experience of communicating complex cybersecurity concepts to a wide range of audiences and enjoys making presentations both thought-inspiring and enjoyable.

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur. She is the founder and CEO of OKRA Technologies – an artificial intelligence data analytics company for healthcare. OKRA allows healthcare professionals to combine all their data in one place and generate actionable, evidence-based insights in real time, to save and improve human lives. Loubna is currently a member of the European Union High-Level Expert Group on Artificial Intelligence, where she is particularly focused on healthcare and achieving competitive business impact with AI. She was named an MIT Technology Review Top Innovator Under 35, a Forbes 50 Top Women In Tech, and won several prizes, including CEO of Year 2019 at the Cambridge Independent Science and Technology Awards and Best Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a strong

advocate for diversity, women and challenging the status quo.

Alex Zhavoronkov, PhD, is the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery and biomarker development. Under his leadership Insilico raised over $380 million in multiple rounds from expert investors, opened R&D centers in six countries or regions, and partnered with multiple pharmaceutical, biotechnology, and academic institutions, nominated 8 preclinical candidates, and entered human clinical trials with AI-discovered novel target and AI-designed novel molecule. Since 2015 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for generation of the novel molecular structures with the desired properties and generation of synthetic biological and patient data. Since 2012 he published over 160 peer-reviewed research papers, and 2 books.

He founded and co-chairs the Annual Aging Research, Drug Discovery and AI Forum (9th annual in 2022), the world’s largest event on aging in the pharmaceutical industry. He is the adjunct professor of artificial intelligence at the Buck Institute for Research on Aging.

Thomas Lindahl is the Chief Medical Officer for Unilabs Sweden, a country leader in medical diagnostics. He did his training as a radiologist, as well as a PhD in oncology, at the Karolinska University hospital in Stockholm. After leaving academic medicine Thomas has held many leadership roles within the medical diagnostics business, including the Unilabs TMC on call teleradiology service in Sydney, Australia. His present role includes responsibility for AI and innovation strategy. Being an early AI adopter he has overseen the validation and clinical implementation of several AI tools for radiology and digital pathology.  Thomas is part of the steering comity for the Unilabs Group AI center of excellence.

Arnaud Wilmet, MD is Chief Medical Information Officer at Nuance where he is in charge of the France Medical Accounts. Prior joining the team, he managed a Pediatrics center in Paris for five years and implemented a full patient integrated EHR with success. He joined Cerner France where he applies clinical knowledge to facilitate development, marketing, sales and integration of solutions to improve patient outcomes and raise physician satisfaction in French Hospitals. He relocated 3 years in the USA as a Senior Physician Executive for Cerner Corp. working with major clients. His last role was Chief Medical Officer of H4D, a telehealth provider where he manages the virtual clinics and medical affairs. Dr Wilmet finished medical school at University of Angers as a family practice physician. The breadth of his background has given him a holistic perspective which encompasses both the patient and provider experience.

Ardy Arianpour is CEO & Co-Founder of Seqster the leading healthcare technology company that puts the patient at the center of all their health data. He is a visionary health tech executive with 20+ years driving innovation in biotech and digital health. 

Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics, which sold to Konica in 2017 for $1 Billion.

As a key player in the 2013 landmark SCOTUS decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access with the launch of BRCA testing benefiting patients and family members across the country.

Ardy received his BS in Biological Sciences from UC Irvine and an MBA from Marshall Goldsmith School of Management. He was a Medical, Marketing, and Media’s (MM&M) Top 40 Healthcare Transformer and San Diego Business Journal 40 under 40.

Omar Khawaja is passionate about people, community, frameworks, communication and measurement. Omar is currently Chief Information Security Officer (CISO) at Highmark Health, a blended health care delivery and financing system, employing more than 45,000 people and serving 50 million Americans. Prior to Highmark Health, Omar was at Verizon Enterprise Solutions, where he had product management and marketing responsibilities for their security solutions portfolio with customers in 72 countries.

In order to sustain the effective delivery of security controls at scale, Omar led the development of 14 frameworks and 8 measurement programs. For this focus on sustainability, Highmark’s Information Security & Risk Mgmt program has been profiled by: Wall Street Journal, SANS, Forrester, Gartner, NACD, Reuters, HIMSS, CSO Magazine and others.

Omar’s certifications include SAFe Agilist, human centered design practitioner, CPHIMS (Certified Professional in Healthcare Information and Management Systems), CISSP (Certified Information Systems Security Professional), CCSK (Certificate of Cloud Security Knowledge) and FAIR Risk. Omar has a BS in Electrical Engineering from Georgia Tech and an MBA from University of Virginia’s Darden School of Business.

Omar currently serves on the boards of HITRUST, the FAIR Institute and Leadership Pittsburgh; on the CISO Workgroup of the Blue Cross Blue Shield Association, as an advisor to a half dozen tech firms and as adjunct faculty for the Chief Information Security Officer (CISO) program at Carnegie Mellon University.

Dr Jacob J Visser is an experienced radiologist and proclaimed academician at the Erasmus Medical Center. He is also the Chief Medical Information Officer at the hospital and the Head of Imaging IT and Value-based imaging at the department of Radiology & Nuclear Medicine.  

Dr Visser has been working closely with the hospital & health care industry focused on Radiology since 2006 and has been associated with the legacy institution – Erasmus MC for the past decade. Dr Visser focuses on the intersection of health economics, technology with radiology and focuses on Telehealth, Clinical Informatics, Integrated Diagnostics, and Artificial Intelligence. He is a keen scholar and an illustrious member of many prestigious industry bodies for Radiology and Medical Imaging across the globe. He has written more than 20 critically acclaimed clinical research papers on radiology and nuclear medicine. 

LinkedIn: https://www.linkedin.com/in/jacob-j-visser-7455426/  

A bio-medical engineer and digital health enthusiast with a decade of experience in diagnostic imaging, radiology and Hospital AI. Having extensively worked with radiologists, clinicians, hospital administrations and health tech companies understands and contributes towards effective implementation of AI in healthcare services.

Stanisa Raspopovic is an Assistant Professor of Neuroengineering at the Department of Health Sciences and Technology of the Swiss Federal Institute of Technology, Zurich, Switzerland. He worked as a PostDoc at EPFL, Lausanne, Switzerland 2013-17. He received the MS in Biomedical Engineering with full marks from the University of Pisa, Italy, in 2007 and the Ph.D. cum laude in Biorobotics, from Scuola Superiore Sant’Anna, Pisa in 2011. His research interest is focused on the development of innovative medical devices for treatment of neurologically disabled persons. In particular, he develops mechatronic systems directly interfacing the environment with the residual nervous system. Stanisa achieved the groundbreaking translational research results in the field of sensory restoration in amputee patients. Driven by the desire to share these inventions with the wider population, in 2014 he co-founded SensArs Neuroprosthetics, a spin-off that develops neuroprosthetic systems, which won many international recognitions, and raised several millions of non-dilutive funding. He won several grants from EU and Switzerland in the role of a project leader and is presently the PI of the prestigious ERC starting grant FeelAgain.  

Anita is Product Manager at Omina Technologies. She is responsible for the product management of Justifai. Justifai is an AI as a Service platform that empowers business domain experts to co-create scalable, trustworthy and regulatory compliant AI innovations and bring them to value faster and more efficiently. 

Anita is passionate about AI, product management, innovation management and marketing. Before joining Omina Technologies, she worked as a product manager for NGDATA and Showpad. She also worked as an innovation manager for Boobook consulting. She holds a PhD in Business Administration and Management. She had an academic career in the field of AI and marketing at Ghent University, Manchester Business School and Monash University.

Sam was awarded his PhD in Systems Biology from the Department of Computer Science at the University of Oxford. He conducted research at the Biotech Information & Research Center in Copenhagen and Harvard Medical School on single-cell transcription data sets, and has over 5 years’ experience working in the pharmaceutical industry.

Sam has an extensive problem-solving and explorative toolkit, and he enjoys applying his knowledge in machine learning, R, Python, and drug R&D to challenging projects.

Sam is Head of Bioinformatics, Target & Biomarker Discovery at Abzu, the deep tech startup whose proprietary AI accelerates exploration with simple and explainable models, enabling scientists to bring drugs to market faster.

At home, Sam is an avid runner and is learning Danish by reading Rasmus Klump to his two kids.

Dr Suraj Kapa is the SVP of healthcare at TripleBlind. He practiced as a cardiac electrophysiologist at Mayo Clinic and over the course of his career he has published more than 200 peer-reviewed articles and book chapters, given 100s of invited lectures, and has filed over 30 patents resulting in startups and FDA approved technologies.

He is highly sought after for his views on the future of digital health and healthcare delivery, having advised multiple public companies and startups in digital strategy. Additionally, his work on digital tools to address the pandemic in 2020 and developing algorithms to enable early prediction of disease has been featured in major news outlets.

Antonio Russo leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and is responsible for Innovation within Deloitte Switzerland’s Executive team. His team helps clients leverage the power of artificial intelligence and data to deliver more customer-centric and innovative products and services that catalyse growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global transformations, leveraging new delivery models (GBS/SSC, outsourcing) and innovative technologies (e.g. robotics, machine learning, natural language processing/generation). He helps global organisations review and implement new strategies for business support functions and deploy more effective and efficient services and governance models. Prior to joining Deloitte in April 2013, he held various sales and consulting leadership positions across Europe and was CEO of a start-up company developing brand protection technologies.

Sofiat Akinola is currently a Director of Health Policy and External Affairs at Roche Diagnostics. In this capacity, she works with decision-makers to advocate for access to timely screening and diagnostic tools to improve patient outcomes. Her portfolio includes cervical cancer, women’s health, health system strengthening and resilience, and universal health coverage.

Before joining Roche Diagnostics, Sofiat was a Global Health Lead at the World Economic Forum. Her portfolio focused on keeping populations healthy and health systems transformation – Value-Based Healthcare, Universal Health Coverage, and Healthy Ageing and Longevity. She led the Global Future Council on Healthy Ageing and Longevity at the World Economic Forum, a dynamic platform for leading businesses, governments, civil society organizations, and world-class experts to shape the global healthy aging and longevity agenda. In this capacity, she worked with the community to generate and disseminate new content and insights and engaged with multiple actors to co-create solutions to boost the impact of healthy life expectancy.

Sofiat also has extensive experience in the NGO and Government sectors. She used her monitoring and evaluation skills to support strategies ranging from Fetal Alcohol Spectrum Disorder Initiative to Ending Homeless in Alberta, Canada.

Sofiat has two Masters, one from the University of Oxford on Evidence-Based Social Intervention and Policy Evaluation with a focus on Impact Evaluation, and from Tulane University School of Public Health and Tropical Medicine, where she received her MPH. Sofiat received her Bachelor’s degree from McGill University in Sociology, focusing on Gender, Health, and International Development.

Frank is a Director in the Consulting Practice at Deloitte Switzerland where he leads Life Science Analytics & Cognitive. He has more than 20 years of experience with data and analytics in commercial life sciences. He has delivered various projects solving clients’ business challenges by applying deep business understanding and cutting-edge technology.

Cécile Tardy-Srinivasan leads the DayOne Health 4.0 Accelerator. In this role, she supports international digital health startups to scale up at the interface with biopharma companies. Passionate about advancing healthcare, her focus is on building bridges between the patients, clinicians, startups, and Pharma worlds to enable collaborations.

Previously, Cécile worked at major pharma companies, like Novartis, where she held various roles at country, regional and global levels. She brings a background in finance from working at EY. Striving to improve patients experience and outcomes, she specialized in co-creating solutions for patients and healthcare professionals, working with different stakeholders in the healthcare ecosystem.

Cécile studied Design Thinking at the MIT Sloan School of Management and holds a Master’s in Management from the EDHEC Business School France.

Curious to know more about DayOne Health 4.0 accelerator? More information available on https://www.dayone.swiss/dayone-accelerator/health-4-0/

Edwin has been working as a physiotherapist / healthcare innovator in the Amsterdam UMC university hospital since 1991. As a healthcare innovator he has initiated innovations that have led both to research projects and, when positively evaluated, have been implemented in daily practice; some local, some regional and some national. These innovations encompass projects based on changes in ‘regular’ healthcare as well as eHealth and recently also concern datascience related projects. Our pilot study to detect in hospital fall incidents is currently being implemented in the electronic health record of our hospital. Pubmed: https://pubmed.ncbi.nlm.nih.gov/?term=geleijn&sort=date

A biochemist and health economist with 30+ years in pharmaceutical research and development and experience in various health areas including cardio-vascular therapies and diagnostic imaging.

Valerie heads the business expansion and sales activities for Nuralogix Corporation across the EMEA and LATAM markets. Multi-disciplinary, multi-cultural and multi-lingual, she uses her vast and extensive experience in the various tech sectors over the years to provide a holistic approach when dealing with customers. An “out of the box” thinker and executor, she is a real believer that great professional and personal interactions is the key to long lasting successful business relationships which is reflected in her unique approach. The last few years within the Digital health space, she has been involved in numerous projects for the private and public health sector and has contributed significantly to the dynamic expansion and growth of Nuralogix.

Dr. Noa Hurvitz is a resident in the Department of Medicine at the Hebrew University-Hadassah Medical Center. She was educated in the Hebrew University-Hadassah medical school. Dr. Hurvitz has authored and participated in several clinical trials comprising second-generation artificial intelligence systems for improving the response to chronic medications and the development of digital twins.

Jürg Hutter works as Senior Product Manager in the Digital Health Business Unit at Swiss Post.

He has more than 20 years of experience in working with national and multinational companies in the field of digital health, healthcare, corporate social responsibility and climate change. Together with clients, he is on the road to establish healthcare eco-systems and bring digital health solutions to life. Jürg holds a Master in Environmental Sciences at the Swiss Federal Institute of Technology as well as a Master in Information- and Technology Management at University of St. Gallen.

Find more information about Swiss Post and Digital Health at https://www.post.ch/en/business-solutions/digital-health

Veysel is a Senior Data Scientist and Healthcare NLP Lead at John Snow Labs, improving the Spark NLP for the Healthcare library and delivering hands-on projects in Healthcare and Life Science. 

He is a seasoned data scientist with a strong background in every aspect of data science including machine learning, artificial intelligence, and big data with over ten years of experience. He’s also pursuing his Ph.D. in ML at Leiden University, Netherlands, and delivers graduate-level lectures in ML and Distributed Data Processing. He is also working towards his PhD in Computer Science and is a Google Developer Expert in Machine Learning.

Veysel has broad consulting experience in Statistics, Data Science, Software Architecture, DevOps, Machine Learning, and AI to several start-ups, boot camps, and companies around the globe. He also speaks at Data Science & AI events, conferences and workshops, and has delivered more than 20 talks at International as well as national conferences and meetups.

Associate Professor Sandeep Reddy is an Artificial Intelligence (AI) in Healthcare researcher based at the Deakin School of Medicine besides being the founder/chairman of Medi-AI, a globally focused AI company. He also functions as a certified health informatician and is a World Health Organisation recognised digital health expert. Further, he is a Fellow of the Australasian Institute of Digital Health and a certified health executive with the Australasian College of Health Service Management. He has a medical and healthcare management background and has completed machine learning/ health informatics training from various sources. He is currently engaged in research about the safety, quality and explainability of the application of AI in healthcare delivery in addition to developing AI models to treat and manage chronic diseases. Also, he has authored several articles and books about the use of AI in Medicine. Further, he has set up local and international forums to promote the use of AI in Healthcare in addition to sitting on various international committees focusing on AI in Healthcare.

Since joining the pharmaceutical Industry 25 years ago, Michael has covered roles of increasing responsibility in clinical research, medical affairs and strategic marketing and participated in new medicines launches, large development programs for small molecules and monoclonal antibodies and the day-to-day management of medical affairs, research and commercialisation at Country, Regional and Global level.

Michael pursued a postgraduate career in Surgery and Surgical Oncology in the UK and in Germany gaining an MD in myocardial preservation in 1989 and became a Fellow of the Royal College of Physicians and Surgeons in 1992. He also gained an MBA in 1999, a specialist registration in pharmaceutical medicine in 2005 and is a fellow of the Faculty of Pharmaceutical Medicine at the Royal College of Physicians and was awarded an honorable Global Fellowship in Medicine Development title in 2020

Michael has published scientific papers on the use of artificial intelligence in medicine, various hematology indications, surgery, breast cancer, sarcoma targeted small molecules, mToR and general aspects of pharmaceutical medicine

Mukesh co-founded Phable in 2018, along with his partner Sumit Sinha. Before founding Phable, Mukesh had extensive experience in market research and analytics having worked with Borderless Access and Kantar. During his career, Mukesh has pioneered new research methods and technologies for consumer behaviour tracking basis which he built a new multi-million-dollar revenue line that was eventually acquired by AC Nielsen for an undisclosed sum. Mukesh holds an engineering degree and masters from Birla Institute of Technology and Science, Pilani and is a part of the country’s young founders’ league. 

Anuraag has extensive experience in building technology products for Healthcare providers, payers, and beneficiaries. His work on reducing Health Insurance Fraud gave him a unique view into challenges of standardising healthcare data and later, at Practo, he worked extensively on simplifying EMR creation for practitioners at Hospitals and Private Practice. He has over 24 years of experience in building technology products for B2C & B2B applications in Education and Healthcare domains.  He is an alum of IIT-BHU Varanasi, India.

Mame Daba DIOUF, Business Unit and Project Manager

Engineer in computer networks and multimedia communication, Mame Daba Diouf has 8 years of experience in the field of ICT.

She has led around twenty “digital for impact” projects applied to solar energy, NGO and association management, banking, microfinance, trade, and mobile applications for social and behavior change.

Since 2018 at IT4LIFE she puts her skills to the service of this social enterprise : 28 programming languages and frameworks; Databases; Agile project management methods (SCRUM certified); and Project Management.

She is interested in applying innovative technologies to meet the needs of underserved populations, with a focus on women’s health and hygiene issues.

As Associate Director of the Changeons Les Règles programme, Daba has played a major role in resource management, strategic oversight, user testing of WeerWi mobile application, scope management, testing and feedback, personal data collection declarations follow-up. She looks forward to being part of future high-impact ICT projects that change the lives of millions of girls and women, particularly in Africa.

Kapsule co-founder with an eclectic background spanning medicine, law and machine learning. While working in an East African hospital, he identified many challenges in African healthcare. He then tried to understand the root causes and noticed a huge lack of data. Hannan then decided to find ways to capture and structure healthcare data to enable evidence-based decision making and drive patient outcomes.

A seasoned nurse practitioner with over 20 years experience who has dedicated her life to the improvement of healthcare for patients across the continent. She has also taught at many universities in Cameroon and Innocentia holds a Masters Degree in Internal Medicine and a Ph.D in Public Health.

Niels is Partner and Health Innovation Director in a global award-winning innovation studio. He has extensive experience in working in and with health start-ups through a wide-array of incubation trajectories. Associated to the Novartis Foundation’s HealthTech Hub in Kigali, he is currently serving as a Strategic Advisor for the African HealthTech Start-up “Klarah – The Uber for home care in Sub-Saharan Africa”. The Klarah solution guarantees peace-of-mind to Africans residing outside the continent, by allowing them to deliver quality home nursing care to their loved ones back at home.

Theophila oversees the design and development of E-Heza Data Solutions software and leads the scale up of E-Heza across health facilities and villages in Rwanda. She uses her exceptional leadership skills to bring together software designers, developers, implementation experts, and frontline health workers to successfully expand E-Heza. Since 2020, Despite the challenges associated with the covid-19 pandemic, her leadership led to a four-fold increase in the number of women and children served on E-Heza. She utilizes her expertise in stakeholder engagement to support the organization in external relations with new and existing partners, as well as the Rwandan government. She was chosen as a finalist for the Commonwealth Digital Health Awards 2020 and 2022. Theophila has a passion to build digital solutions that contribute to the improvement of health outcomes and community engagement through health systems digitalization.

Aloys Rukundo is the Founder & CEO at Hellomed a virtual medical Consultation Platform based in Kigali, Rwanda. Prior to this, Aloys Co-Founded Watotosmile Ltd a social enterprise improving literacy to children (girls) from low-income households. He holds a Bachelors’ Degree in Banking and Finance,  and is very passionate about improving Public Health in Africa using Technology. Aloys, loves travelling, spending time with family and watching basketball.

Over 30 years of executive experience with major listed corporation in the IT Industry.

Conducted business in almost 40 international markets within many business sectors (including over 20 sub-Sahara Africa markets and other developing economies).

Mr Clivate Maiba is a 23-year old Award-winning innovator and experienced clinician who is passionate about health promotion, disease prevention, entrepreneurship, and digital healthcare, he believes that preventive measures are always better to approach than curative care. He is currently pursuing a BSc. In public health and holds a diploma in clinical sciences.

He is a Co-founder and chief operations officer of Health Literacy Zambia, a non-profit organization that aims to promote health education and practices in vulnerable communities. Over 18,000 Zambians have so far benefited.

Mr. Maiba serves as an executive director at Denga Logistics limited, a digital health start-up optimizing and automating lab reports, a network of motorbikes, and drones connecting hard-to-reach health facilities with medical supplies, state-of-the-art laboratories, and state-of-the-art blood banks. Denga is on a mission of taking essential health services to hard-to-reach remote communities

Clive’s passion for innovations had led him to participate in two hackathons organized by the Massachusetts Institute of technology and a good number of hackathons.

He worked on a digital health project that would monitor chronic patients living with hypertension and diabetes in real time, he received business and technical support from ZICTA but along the way, he resorted to putting the project on hold.

Clivate has so far volunteered in numerous organizations both locally and internationally, in the year 2019, he was awarded an ambassadorship of hypertension. He volunteered as a student against COVID, he also volunteered at copper rose Zambia as a sexual and reproductive health rights advocate. He is a 2022 ambassador at Bukovinian International Medical Congress and a former hypertension ambassador at the international society of hypertension.

He has undergone leadership, business, and entrepreneurship training. He is a 2021 semi-finalist at Harvard Cross Roads Emerging leaders’ program, He is one of the 34 African fellows at the African Oxford Initiative-Health innovation program, a Young African Leadership initiative (YALI-RSA) Alumni, and an Award-winning innovator at the 2021 National Innovation Initiative (supported by; UNDP, UNFPA, ZICTA, PACRA, Finish Government). He is among the top 30 in the next Gen incubation program by the jacaranda hub from over 2000 participants.”

Founder of Insightiv, a Rwandan medical imaging diagnostics startup.  MIT Computer Science and Economics graduate, with years of experience as engineer and Researcher in areas of Artificial Intelligence and Machine Learning, and their applications in Health and Speech Recognition. Published author in world-class journals such as Frontiers of Artificial Intelligence.

Amos Ankrah MSC is Boston’s Solution Specialist focusing on Product Management within Boston Medical Systems (BMS). Amos has 25 plus years of experience working in IT, however, before commencing his career in IT he gained a degree in Biochemistry and Pharmacology at Kings College London.

Amos and his team are driving the evolution of Boston Medical Systems with the delivery of a novel approach to drive the detection of anomalies in large organs. This role enables Amos to work on two career passions, the evolution of IT technology and the application of AI in Pharmacology.

About Acrux Cyber Services

Mechanical ventilation saves lives but causes lung injury and pneumonia.

Solving these problems requires highly qualified specialists and constant monitoring of the patient, which is impossible.

Yana Kozis is the CEO & Founder of Debaby, a startup from Ukraine aimed to help women struggling with infertility by providing mental health support. 

Before starting her venture, she was a part of a start-up team in the childcare field. In addition to 5+years of Operations and Customer Support experience with SaaS products and the commerce field, she has 4 years of content creation experience and an MBA degree. 

She’s passionate about technological innovations in the reproductive health area and focused on creating a meaningful product that has an impact on one of the sustainable development goals.

Steven Truong is the Founder and CEO of VinBrain, a subsidiary of Vingroup, the largest conglomerate in Vietnam. He has been in the AI and software industry for more than 26 years and has held senior leadership positions in top technology companies in the USA and Canada, including Microsoft, Honeywell, and IntelliCommunities. Before he formed VinBrain, he was the Director of AI Incubation and Engineering at Microsoft in the USA, reporting directly to the VP of MSAI. Steven has led multi-development center teams at Microsoft. He has been a key innovation initiator for AI products that have been used by millions of users worldwide, such as Email Smart Reply and iRanker. Steven established VinBrain with the mission to infuse AI and IoT to improve human lives and productivity. He has led his team to deploy DrAid – the 1st AI-powered doctor assistant in Vietnam – to more than 100 hospitals across Vietnam and the USA. VinBrain also served thousands of Vietnamese COVID-19 patients through VinBrain’s second flagship product, AIviCare, for telehealth. VinBrain won ACM SIGAI Industry Award in 2021 – previously, Microsoft was the only winner.

Luca Emili is an entrepreneur and investor, founder and current CEO of InSilicoTrials Technologies, the first global platform that makes easy-to-use modeling and simulation to accelerate the pace of innovation in the healthcare and life science industry. From 2001 to 2010 he was CEO of Emaze, a cybersecurity company that became one of the market leaders in Italy by automating security analysis for complex networks and devices. He is member of the Cloud Security Consultative Group in EMA and is responsible for the RCA Research Collaboration Agreement between InSilicoTrials and the FDA. He is also member of the Board of Avicenna Alliance and of the committee for the adoption of the In Silico Medicine of the Italian Ministry of Health.  He also worked in M&A and his many passions brought him to be a journalist, an entrepreneur in the internet services business, a startup investor and an IT lecturer at the MIB School of Management of Trieste. He holds a degree in Economy and Business from the University of Trieste, Italy, where he still lives today when he’s not traveling across the USA and Europe. 

Dylan Johnston is the founder and CEO of MOD1 AG and one of Switzerland’s leading cybersecurity experts. His organisation provides strategic, tactical and operational consulting services in cybersecurity, privacy, risk management and regulatory compliance to organisations in the digital healthcare, MedTech, BioTech and pharmaceutical space.

Dylan has over 20 years of experience designing, executing and overseeing security and privacy programs for organisations in highly regulated business sectors, where a comprehensive, risk-based approach to protecting critical information assets is central to corporate missions and business success.

Dylan holds a B.Sc. in Business Information Technology from the University of Bedfordshire, an M.Sc. in Information Security at Royal Holloway, University of London, and is currently a doctoral candidate (Information Security) at the University of East London.

André has twenty years of cumulative professional experience, mainly in roles related to Marketing&Sales in the tech industry. As Chief Commercial Officer of Giotto.ai, he is part of a top-notch team on a mission to redefine how Humans and Artificial Intelligence should work together on healthcare regulatory activities.

Helge Buess joined the Novartis Foundation in September 2022 as Associate Director Population Health. He supports the implementation and impact measurement of the Foundation’s initiatives that drive data and digital-led innovations to improve urban population health and narrow health inequities.

After roles in Sales and Marketing at Astellas Pharma AG, Helge joined the Oncology Business Unit of Novartis Switzerland in 2018 as Disease Area Manager. In this position, he was responsible for maximizing the commercial growth of products in the local hematology portfolio.

In 2021, Helge was appointed Strategic Assistant to the Swiss Country Head, supporting and driving strategic projects in Novartis’ Pharma Business Unit such as the development of the Country Organisation’s strategic roadmap as well as the design and implementation of transformation projects.

Helge graduated from the Swiss Federal Institute of Technology (ETHZ) with a PhD in Molecular & Cellular Biology and from the University of St. Gallen (HSG) with an Executive MBA in General Management. Due to prior roles, Helge refers to hands-on experience in biomedical research, product marketing, matrix leadership, external stakeholder engagement, project management and strategy building.

After a Ph.D. in Machine Learning applied to healthcare and life sciences at ETH Zurich, Matteo Togninalli is now the Chief Operating Officer at Visium. He provides applied ML expertise to Visium’s clients and gives technical and strategic guidance to the delivery teams at Visium. With his academic experience from EPFL, Stanford, and ETH in combination with his professional track record, Matteo has helped many of Visium’s clients to translate business needs into technical solutions leading to various breakthroughs for Roche, Novartis, Incyte, and many more.

Theresa Reiker is Associate Director of Population Health at the Novartis Foundation. In her role, Theresa supports health systems across the globe in harnessing the power of data to improve the health of their populations.

As a former biologist, turned machine learning enthusiast, turned public health professional, Theresa is excited to build bridges between fields. The global quest to improve population health requires intersectoral collaborations between diverse partners. Theresa sees herself as a connecting node in this network. Through her academic training at the Universities of Oxford and Cambridge and her PhD at Swiss TPH, she attained broad expertise in using real-world data and computational techniques for health, but also in health systems and policy planning. Her expertise spans the applications in health planning of classical data science, genomics, simulations and AI methods. Publications: click here

Andrew Addison is a senior software engineer with nearly 30 years of experience in the financial services industry.  He graduated in Computational Science at St. Andrews University in 1990 and spent several years working in core development for a 4GL company specialising in compiler writing. With a deep understanding of technology, Andrew has developed and deployed high-volume distributed computational solutions for major investment banks such as Salomon Brothers, JP Morgan, Merrill Lynch, SwissRe, Bank of America, Deutsche Bank as well as several well-known hedge funds. Andrew is very well versed in the security risks that business face today and is in regular dialogue with like-minded individuals through his vast network.

Ulla is the Governance and Policy Lead at Fondation Botnar. She holds a PhD in Political Science and a Master of Advanced Studies degree in Public Health (MPH). Before joining Fondation Botnar, she worked as a Senior Researcher at ETH Zurich. At Fondation Botnar she is responsible for managing the policy work and for coordinating external relations and partnerships.

Eric Topol is the Founder and Director of the Scripps Research Translational Institute, Professor, Molecular Medicine, and Executive Vice-President of Scripps Research. As a researcher, he has published over 1,200 peer-reviewed articles, with more than 310,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the genomic and digital tools to individualize medicine.

In 2016, Topol was awarded a $207 million grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program enrolling 1 million participants in the US. This is in addition to his role as principal investigator for a flagship $35M NIH grant to promote innovation in medicine. He was the founder of a new medical school at Cleveland Clinic, Lerner College of Medicine, with Case Western University. He has over 440,000 followers on Twitter (@EricTopol) where recently he has been reporting insights and research findings for COVID-19. Besides editing several textbooks, he has published 3 bestseller books on the future of medicine: The Creative Destruction of Medicine, The Patient Will See You Now, and Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again. Lastly, Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies.

Dr. Laura Matz is the Chief Science and Technology for Merck, driving innovation and digitalization in Merck across the 3 business sectors, Life Sciences, Healthcare and Electronics.    Serving as an executive vice-president within Merck, she is responsible for the corporate innovation teams including the digital office and new digital business models.  She possesses 20 years of experience in semiconductor manufacturing and a decade of experience running semiconductor materials businesses. 

Prior to becoming the CSTO, she was a senior vice-president within EMD Electronics (previously Versum Materials and Air Products Electronics division). She has always been a key contributor to the growth in semiconductor materials, driving for a strong R&D presence to enable business growth.  

Laura is a strong advocate for science and engineering in young talent.  She has collaborated with ASU over the past 5 years to build a strong pipeline of interns.  In 2020, Laura joined the AICHE (American Institute of Chemical Engineers) ILI board (Institute for Learning and Innovation) which serves as a conduit for advancing chemical engineering talent for the U.S.    Given that artificial intelligence and machine learning are enablers for the continued growth in the semiconductor industry, she is a member of the SEMI Smart Manufacturing board as well as the local AZ SEMI board. 

Laura has a PhD in analytical chemistry from Washington State University and undergraduate degree from Indiana University of Pennsylvania.  When she is not working, Laura enjoys watching soccer games and running in the beautiful Arizona weather.

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, neuroscientist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare vertical for Google Cloud. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application and served as Interim Chair of System Radiology. His prior appointments include Los Alamos National Laboratory (University of California), Wayne State University School of Medicine, Children’s Hospital of Michigan and Penn State University Hershey Medical Center where he was a tenured Professor in the College of Medicine. Greg currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and holds degrees from North Park College-Chicago (BS), Massachusetts Institute of Technology (SM-Nuclear Engineering and PhD-Radiological Sciences), and Wayne State University School of Medicine (MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

Carolyn Starrett is CEO of Flatiron Health®, a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments.

Almost everything known today about what works for patients with cancer comes from the relative few who enroll in randomized controlled trials. Flatiron uses clinical and data science to improve lives by learning from the experience of every cancer patient. Insights from Flatiron’s U.S-derived real-world data and analyses support meaningful learnings relevant to a global cancer population, and have helped expand treatment alternatives for people with gastric, colorectal, esophageal, breast, and head and neck cancer. Through three international subsidiaries, Flatiron now also works to improve treatments and outcomes for cancer patients in Japan, Germany and the United Kingdom.

Carolyn became Flatiron CEO in April, succeeding the company’s co-founders and bringing a deep understanding of the challenges facing those on the cancer frontlines from her years leading the company’s community oncology business. Prior to joining Flatiron in 2016, Carolyn held senior strategy, product and operations roles at data and technology companies, and worked with healthcare and technology companies as a principal with Boston Consulting Group. Carolyn holds an MBA from the Kellogg School of Management at Northwestern University and a Bachelor’s degree from Brown University.

Le Lu received a Computer Science PhD in 2007 from Johns Hopkins University. During his first six years at Siemens, he made significant contributions to the company’s CT colonography and Lung CAD product lines. 

From 2013 to 2017, Dr. Lu served as a staff scientist in the Radiology and Imaging Sciences Department of the National Institutes of Health Clinical Center. He then went on to found Nvidia’s medical image analysis group and he held the position of senior research manager until June 2018. From 2018 to 2021, he was the Executive Director at PAII Inc., Bethesda Research lab, Maryland, USA which has become one of the leading industrial research labs in medical imaging. 

He is currently the global head of Medical AI R&D for Alibaba group. He was the main technical leader for two of the most-impactful public radiology image dataset releases (NIH ChestXray14, NIH DeepLesion 2018). 

He won NIH Clinical Center Director Award in 2017, NIH Mentor of the year award in 2015, and won numerous best paper awards in recent MICCAI and RSNA technical and clinical conferences from 2016 to 2021 (over 11600 citations). In 2021, He was elected into IEEE Fellow class cited for his contribution to machine learning for cancer detection and diagnosis, and MICCAI society board member (MICCAI-Industry Workgroup Chair). He is currently an Associate Editor for IEEE Trans. Pattern Analysis and Machine Intelligence and IEEE Signal Processing Letters. He has published more than 200 peer-reviewed articles and leading conference papers in Nature Communications, Clinical Cancer Research, IEEE TMI, MedIA, etc. He is the (co-)inventor of 69 USPTO/PCT patents (granted or pending).

Jeroen Tas is responsible for Strategic Business Development at Philips and former Chief Innovation & Strategy Officer at Philips. He has more than 35 years of global experience as an entrepreneur and executive in the healthcare, information technology and financial services industries.

Jeroen is closely involved with the company’s strategy, platforms, ventures and emerging businesses. In his current position in Strategic Business Development, he plays a central role in coaching digital business ventures and leadership and is involved in strategic projects to create new models of people-centric healthcare. He leverages emerging technologies such as artificial intelligence, robotics and the Internet of Things to reinforce the company’s health propositions aimed at supporting consumers, care professionals and health systems with personalized, connected health solutions. 

Jeroen’s stance is echoed in Philips’ commitment to touch the lives of billions and improve better health outcomes at lower cost: from healthy living and prevention to diagnosis, treatment and home care. 

A respected thought leader, Jeroen was responsible for turning around Philips’ healthcare IT business and has been instrumental in establishing HealthSuite as the new open industry standard for the ‘Healthcare Internet of Things’ Cloud platform.

Jeroen joined Philips in 2011, leading IT worldwide as Group Chief Information Officer (CIO). In 2014 he became CEO of Philips Healthcare, Informatics Solutions & Services, overseeing digital health and clinical informatics. From 2016, Jeroen led the company’s Connected Care and Informatics businesses, demonstrating a passion to create new models of people-centric healthcare, based on the power of information technology.

Before joining Philips, Jeroen co-founded and served as President, COO and Vice-Chairman of the board for MphasiS, an IT and Business Process Outsourcing company, which was acquired by HP in 2006. Prior to MphasiS, he was the head of Transaction Technology, Inc., Citigroup’s tech lab, responsible for the innovation and development of the bank’s customer-facing systems, including Internet banking and self-service devices. From 2007-8, he was Vice President and General Manager at EDS, responsible for the company’s global competency centers.

Sir Nigel Shadbolt is Principal of Jesus College and Professor of Computing Science at the University of Oxford, where he has centred his research in human centred AI in a wide range of applications.  Most recently he was asked to lead the setting up of the Oxford Institute of Ethics in AI.  He is also the Chairman and Co-Founder of the Open Data Institute (ODI).  Since 2009, Sir Nigel has helped transform public access to Government information.

In 2010, he joined the UK government’s Public Sector Transparency Board – overseeing Open Data releases across the public sector.  He was knighted in 2013 for ‘services to science and engineering’. 

With over 500 publications, he has researched and published on topics ranging from cognitive psychology to computational neuroscience, Artificial Intelligence to the Semantic Web.  In 2018 he published The Digital Ape: how to live (in peace) with smart machines, described as a ‘landmark book’.

He is a Fellow of The Royal Society, the Royal Academy of Engineering and the British Computer Society.

Dr Sujoy Kar is the Chief Medical Information Officer & Vice President at Apollo Hospitals. Previously, he was the Director Medical Services at Apollo Gleneagles Hospitals Kolkata. He obtained his post graduate MD in Clinical Microbiology & Infectious Diseases and is an alumnus of MIT Sloan School of Management. He is a Certified Six Sigma Master Black Belt (Indian Statistical Institute) and member of professional organisations like ACHE, VRARA (Member – Healthcare Sub Committee), CHIME, Harvard Square (LE), ICMR – CIBioD (Member Task Force) and World Economic Forum – Chatbot & AI in Healthcare.

Dr Sujoy is currently associated with IIT Kharagpur & IIM Calcutta as Adjunct Faculty for Healthcare Analytics and Management. He has led teams in multiple award winning Patient Safety & Process Improvement projects. His current and ongoing research interests are in adoption of Artificial Intelligence & Blockchain Technology in Healthcare, Time Driven Activity Based Costing, Living Labs, Digital Health Platforms and Design Thinking in Healthcare.

Dr. Junaid is a practicing physician in the NHS and is also the Chief Medical Scientist at Microsoft Research. He also serves as a Non-Executive Director at University College London Hospitals NHS Foundation Trust. He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme (Merck & Co), where he helped shape their global digital strategy. Junaid also has experience in the academic world where he is a Clinical Associate Professor at University College London (UCL), and a Visiting Scientist at the Harvard School of Public Health. Over the past 15 years, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer,and policy maker within the UK, where he specialised in informatics, digital transformation, and leadership. He has also acted as a consultant for health care systems across the US, Australia, New Zealand, Singapore, the Middle East, and Europe.

Dr. Lungren is the Co-Director of the Stanford Center for Artificial Intelligence in Medicine and Imaging and Medical School Faculty in the Department of Radiology at Stanford University Medical Center. Dr. Lungren’s NIH and NSF funded research is in the field of AI and deep learning in medical imaging, precision medicine, and predictive health outcomes. His work has been featured in national news outlets such as NPR, Vice News, Scientific American and he regularly speaks at national and international scientific meetings on the topic of AI in healthcare.

Effy Vayena is a Professor of Bioethics at the Swiss Federal Institute of Technology (ETHZ) and renowned expert at the intersection of medicine, data, and ethics. Her work focuses on how emerging technologies in biomedicine and data analytics affect our society and what ethical safeguards we should put in place to avoid negative consequences. To address these questions, she uses different research methodologies. She founded and directs the Health Ethics and policy Lab, an interdisciplinary research lab including philosophers, social scientists, lawyers, biologists and engineers.

Vayena has been appointed Faculty Associate at the Berkman Klein Center for Internet & Society at Harvard University, where she was previously a Fellow. She has published over a hundred peer-reviewed articles and book chapters and co-edited several books. Vayena is also an elected member of the Swiss Academy of Medical Sciences. She chairs the Ethical, Legal and Societal Implications advisory group for the Swiss Personalized Health Network, a national infrastructure and research program which aims to advance personalized healthcare in Switzerland. She currently co-chairs the WHO’s expert advisory group on Artificial Intelligence health ethics and governance. She is also a member of the Swiss COVID19 Science Task. Vayena frequently advises governments and public policy organizations on matters of digitization and ethics.

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program.  From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone). From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic.  Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala.  

Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts.  Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries.  Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

Pieter Jeekel is chairman of the Netherlands AI Coalition for Well-being & Healthcare and director and founder of Evodoc and The Social Health Company. Pieter has a background as an eHealth entrepreneur and leader of nationwide healthcare reform programs.

Eleonora is Head of Collaborations of NHSX’s AI Lab. Her work focuses on communicating and engaging with health and care professionals, the public and industry to support and share the work of the NHS AI Lab and the potential of AI. She has co-authored papers on AI in the NHS, the value of healthcare data, commercial models in healthcare and the regulation of data-driven technologies. She is a member of the British Standards Institution’s Committee on Artificial Intelligence and the London Hub Lead of One HealthTech, a grassroots community which seeks to promote diversity in healthtech.

Prof. Dr. Max Welling is a research chair in Machine Learning at the University of Amsterdam and a VP Technologies at Qualcomm. He has a secondary appointment as a fellow at the Canadian Institute for Advanced Research (CIFAR). Max Welling has served as associate editor in chief of IEEE TPAMI from 2011-2015. He serves on the board of the Neurips foundation since 2015 and has been program chair and general chair of Neurips in 2013 and 2014 respectively. He was also program chair of AISTATS in 2009 and ECCV in 2016 and general chair of MIDL 2018. He is a founding board member of ELLIS. Max Welling is recipient of the ECCV Koenderink Prize in 2010. He directs the Amsterdam Machine Learning Lab (AMLAB) and co-directs the Qualcomm-UvA deep learning lab (QUVA) and the Bosch-UvA Deep Learning lab (DELTA). He is a fellow and founding board member of the European Lab for learning and Intelligent systems (ELLIS).

Naomi Lee is a Senior Executive Editor at The Lancet. She heads the research section of the journal, and handles peer review and commissioning across a broad range of subjects including her specialist areas of surgery, oncology, digital medicine/AI, and medical technology.  She is also a vice chair for the ITU/WHO Focus Group on Artificial Intelligence for Health. Naomi joined The Lancet in 2014. Previously she studied medicine at Cambridge University and King’s College London, before training in surgery, specialising in urology and working for almost 10 years in the UK. She has completed fellowships in Argentina and Mexico. She has also studied data science at University College London.

Dr Stefan Germann is the CEO of Fondation Botnar, a Swiss-based foundation which champions the use of AI and digital technology to improve the wellbeing of young people in urban environments. To achieve this, the foundation supports research, catalyses diverse partners, and invests in scalable solutions around the world.

Dr Germann has spent over 25 years working in various leadership roles in Africa and Asia, focusing on health-related development for children, relief and advocacy work. He was previously the Senior Director of World Vision’s International Sustainable Health Partnership, Innovation and Accountability unit based in Malaysia. His work focused on a complex relief and reconstruction program in response to the Asian Tsunami. 

He has previously held several board and advisory board memberships. These include for the Partnership for Maternal, Newborn and Child Health (PMNCH), UBS Optimus Foundation, REPSSI in Africa, the Global Health Program and The Graduate Institute in Geneva, where he focused on the role of NGOs in global health diplomacy.

Emmanuel Akpakwu has been the Chief Commercial Officer for Novartis’s SubSaharan Africa region since April 1st 2020. Reporting to the Regional Head, he and his team are responsible for driving the Commercial Strategy and execution of Novartis’s Sub-Saharan Africa mandate to expand patient reach across the full income pyramid and reach the full billion.

Emmanuel joined Novartis in January 2019 as Director of Corporate Strategy, reporting to the Head of Corporate Strategy. Prior to that, he led the Value-Based Healthcare Practice of the World Economic Forum in Geneva and was Associate Director of Corporate Strategy at Merck. His career started at JP Morgan Investment Bank in London.

Emmanuel holds a Bachelor of Science in Computer Science from the University of Hertfordshire, England and an M.Phil./MBA from the University of Cambridge, England. He also completed an Advanced Executive Education Certificate in Value Measurement for Healthcare from Harvard Business School.

Babita Sharma is a BBC News presenter, regularly seen on the BBC News Channel, BBC World News, and presenting the show Newsday.

Babita has presented the finance programme Your Money, and fronts business reports for BBC News. She has also covered economic and political stories from around the world.

Chris is a data scientist and developer at TPP and holds a PhD in Mathematics from the University of Manchester. Chris leads TPP’s work in the use of EHR data to support analytics, research, and surveillance. He has previously been recognised by the Health Service Journal (HSJ) as one of the top 50 innovators in UK healthcare.

In recent years, Chris led the TPP team which contributed to the development of the national Electronic Frailty Index (eFI). He is involved in a number of national research programmes, including in cancer survivorship and antimicrobial resistance. He works closely with the UK Biobank team, helping to combine EHR data with genomic information to support their vital research.

Chris also has a strong interest in clinical terminologies and open standards for interoperability. He has spoken on many digital health topics at large conferences, including at both SNOMED CT Expos and at Health Datapalooza in the US. He is an active researcher and has co-authored a number of academic papers in prominent journals, such as Science.

As part of TPP’s response to the Covid-19 pandemic, Chris has been a key member of the OpenSAFELY collaborative and has helped build a large, secure platform for national Covid-19 research. He is also leading TPP’s support of the PRINCIPLE trial at the University of Oxford, aiming to discover whether selected treatments can improve Covid-19 outcomes.

Maurice van den Bosch (1974) studied Biomedical Health Sciences (MSc) and Medicine (MD) at the Radboud University Nijmegen, the Netherlands. He finished his PhD-thesis in the field of Epidemiology at the University of Utrecht in 2001, and became a resident in Radiology at University Medical Center (UMC) Utrecht (2002 – 2007). 

He did a postdoctoral fellowship Interventional Radiology at Stanford Medical Center (2007-2008) USA. In 2009 he obtained a faculty position as Interventional Radiologist in UMC Utrecht. He was appointed Professor of Interventional Radiology in 2011. 

Maurice van den Bosch has published more than 200 peer reviewed manuscripts in the field of cancer imaging and interventions. He is member of several international advisory boards, including CIRSE Foundation Advisory Coucil and European School of Radiology (ESR) Leadership Institute.

In 2014 he became Chairman of the department of Radiology and Nuclear Medicine in UMC Utrecht and was appointed Medical Director of the Center for Image Sciences, UMC Utrecht. In 2017 he became member of the Executive Board OLVG hospital Amsterdam and per April 2018 he was appointed Chairman of the Board of Directors.

Meri Petrovska is a Knowledge Management Director at AstraZeneca. She is a product owner of the Real World Knowledge Management platform and the Publications Systems at AZ.  Meri’s background is in software development and data analytics. 

Prior to joining AstraZeneca, Meri was Head of Business Intelligence for Specialised Commissioning at NHS England (Midlands and East), with responsibility for the Informatics Contracts with the hospitals, data collection and analysis, and where she developed a special interest in drugs data and patient pathways.

Ameen Abu-Hanna is full professor at the department of Medical Informatics at the University Medical Centers and the University of Amsterdam. He is Principal Investigator in the research area of Methodology in Medical Informatics with interest in statistical machine learning (including development and validation of models for risk prediction, pattern recognition, and sub-group discovery), NLP, causal inference, decision support systems, and impact studies of IT systems. He was a former head of department; president of the European Society of Artificial Intelligence in Medicine; and associate editor of Journal of Biomedical Informatics. In 2017 he has been elected a founding member of the International Academy of Health Sciences Informatics. Ameen has a BSc (Cum Laude) in computer engineering, MSc in computer science, and a PhD in Artificial Intelligence.

Prof. Andre Dekker, PhD (1974) is a medical physicist and professor of Clinical Data Science at Maastricht University Medical Center and Maastro Clinic in The Netherlands. His Clinical Data Science research group (40 staff) focuses on 1) federated FAIR data infrastructures, 2) AI for health outcome prediction models and 3) applying AI to improve lives of patients and citizens. Prof. Dekker has authored over 200 publications, mentored more than 30 PhD students, and holds multiple awards and patents on the topic of federated data and AI. He has held visiting scientist appointments at universities and companies in the UK, Australia, Italy, USA and Canada.

Marloes Pomp is the Initiator and Program Officer for the blockchain and AI projects within the Dutch Government, including projects in the field of digital identities, logistics, healthcare, finance and food. She is also responsible for the international strategy and partnerships of the Dutch Blockchain Coalition  and the National AI Coalition. Both coalitions are a jointly developed partnership by government, industry and knowledge institutions. Together they have a leading role and joint responsibility for the success of the solving societal challenges and making a major contribution to new economic activities.

She is also a member of the Steering Committee of the European AI Forum, a

platform where entrepreneurs and policymakers get together to jointly determine the path forward for European AI innovation. 

Marloes her professional interests focus on tech-innovation within governments. Prior to the blockchain and AI activities, Marloes Pomp worked in several roles like projectleader and researcher at governmental organizations, including the ministry of Interior and Kingdom Relations and the city of Amsterdam. In addition, she serves as an advisory member for the SIDN Fund, the Dutch Court, The Blockchain and the Society Board of the University of Amsterdam (VU).

Reza is currently the chief scientist at AIG, and a principal investigator (in machine learning and medicine) at Deep Medicine program of The University of Oxford. His current research at Oxford is focused on probabilistic machine learning, and neural sequence models, for biomedical informatics, population health, and precision medicine; more specifically, he is interested in using machine learning for the development of personalized health predictions and recommendations, as well as an improved understanding of multimorbidity. Reza’s team at AIG (i.e., Investments AI) is a group of scientists, engineers, designers, and product managers, focused on the development of AI-first products in the investments and FinTech space.

Bart-Jan Verhoeff studied medicine at the University of Amsterdam and specialized in nephrology at the Academic Medical Center in Amsterdam. Since 2012 he works as an internist-nephrologist in St Jansdal Hospital in Harderwijk. Since 2016 he has been involved as CMIO in innovation and optimization of digital care processes at St Jansdal. Shortly after, he became enthusiastic about the possibilities of artificial intelligence and started the blog dokter.ai to write about opportunities and pitfalls of AI for healthcare. At the same time, he started developing machine learning algorithms driven by the vision that healthcare should be the owner of algorithms for healthcare. This year, Bart-Jan and ‘Samenwerkende Algemene Ziekenhuizen’, the umbrella organization of 28 general hospitals in the Netherlands, founded the company ‘Expertisecentrum Zorgalgoritmen’ (Expertise Center for Healthcare Algorithms) to develop AI for healthcare and to help healthcare organizations with implementation of AI in clinical practice.

Jildau Bouwman works as senior scientist at TNO, the Netherlands. She leads the “digital health technology” roadmap of TNO, that is focusing on health data and development of non-invasive sensors. Her work focusses on omics data interpretation (transcriptomics and metabolomics), data analysis and data management. The goal of her work is to reuse data to improve public health. This requires data from the whole system (omics data) and from multiple sources (wearables, human (intervention) studies and hospital data).

She leads the Public-Private-Partnership projects C4yourself and Connect2HealthConsumer, both projects aiming toward privacy-by-design reuse of health data. She is one of the driving forces behind the development of the Phenotype database, as system developed to store and reuse nutritional (meta)data. Her vision is that for the reuse of data a rich set of meta data is crucial. She is coordinator of the Food&Nutrition ELIXIR community and the JPI HDHL INTIMIC knowledge platform that brings together data on microbiome-diet and health.

Alex Zhavoronkov, PhD, is the founder and Chief Longevity Officer of Deep Longevity, Inc, a global company developing a broad range of artificial intelligence-based biomarkers of aging and longevity. He is also the founder and CEO of Insilico Medicine (insilico.com), a leader in next-generation artificial intelligence technologies for drug discovery, and biomarker development. Since 2015 he invented critical technologies in the field of generative adversarial networks (GANs) and reinforcement learning (RL) for generation of the novel molecular structures with the desired properties and generation of synthetic biological and patient data. He also pioneered the applications of deep learning technologies for prediction of human biological age using multiple data types, transfer learning from aging into disease, target identification, and signaling pathway modeling. Under his leadership Insilico raised over $50 million in multiple rounds from expert investors, opened R&D centers in 6 countries and regions, and partnered with multiple pharmaceutical, biotechnology, and academic institutions. Prior to founding Insilico, he worked in senior roles at ATI Technologies (acquired by AMD in 2006), NeuroG Neuroinformatics, Biogerontology Research Foundation. Since 2012 he published over 130 peer-reviewed research papers, and 2 books including “The Ageless Generation: How Biomedical Advances Will Transform the Global Economy” (Palgrave Macmillan, 2013). He serves on the editorial boards of Aging Research Reviews, Aging, Trends in Molecular Medicine, Frontiers in Genetics, and co-chairs the Annual Aging Research, Drug Discovery and AI Forum (7th annual in 2020) at Basel Life, one of Europe’s largest industry events in drug discovery. He is the adjunct professor of artificial intelligence at the Buck Institute for Research on Ageing. Website: www.Longevity.ai

Frank is a Director in the Consulting Practice at Deloitte Switzerland where he leads Life Science Analytics & Cognitive. He has more than 20 years of experience with data and analytics in commercial life sciences. He has delivered various projects solving clients’ business challenges by applying deep business understanding and cutting-edge technology.

Allison lectures at Keele University in Data Science and is a co-founder of Women Leading in AI, CEO of AI Aware and ForHumanity Fellow. Her research is focused on algorithmic bias; gender and computing; AI Ethics and Governance of AI and health tech. She works on the IEEE P7003 Considerations of Algorithmic Systems and with the ISO and BSI on AI linked standards, sitting on the UK national committee for ART/01 Artificial Intelligence standards and on CEN-CENELEC JTC21. She speaks internationally on AI Ethics, the need for diversity in tech and the potential regulation and governance of AI. Allison acts as a consultant on the ethical design of autonomous and intelligent systems offering training and AI bias audits/AIAs.

Bart Geerts is the founder of Healthplus.ai, an Amsterdam-based startup that focuses on making surgery more proactive by reusing existing data to predict infections and other complications. He is an advisor to NLC which is the largest European Healthtech and Biotech venture builder, and he has worked as an ICU physician at Spaarne Gasthuis throughout the covid pandemic. He is a cardiac-anaesthetist, intensivist and clinical pharmacologist, and has over a decade of clinical research under his belt with papers about machine learning in health care in journals like JAMA and Nature. Bart works also with Edwards Lifesciences and Philips to bring computational intelligence and support to the ED, ICU and OR. His interests are to connect people and creating solutions in teams and consortiums.

Farina is a social entrepreneur, advisor and speaker. In 2016 she founded Selfapy – Germany’s leading therapy platform for people suffering from mental health disorders. As a “growth expert”, she lived in Sydney where she became part of the founding team of the discount portal Groupon. Later she started Airtasker, a platform for mini jobs, which is now listed on the ASX where she led the (international) expansion. During that time, she also founded Sydney’s largest Co-Working Space TSL, which counts more than 400 members today. In 2017, Farina has been awarded as “Top 30 under 30” of Forbes Magazine as well as one of the “25 women, that make the world more sustainable”.

Jen Horonjeff, PhD, is a patient advocate and the founder & CEO of Savvy Cooperative, the first and only patient-owned co-op that helps innovators connect directly with diverse patients in order to get the insights they need to build better and more inclusive healthcare solutions. Jen was named one of the 50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine for her work at Savvy. She grew up with multiple autoimmune conditions and survived a brain tumor as an adult, and is also a patient-centered outcomes researcher, a human factors engineer, and formerly an FDA advisor. Jen strives to give patients a platform to have their experiences be heard, included, and equitably valued.

Baher Al Hakim is the CEO of Medicus AI, an AI-based platform that explains and interprets medical reports and health data, turning numbers into meaningful insights with a global presence.

Baher is a dentist by study and a serial entrepreneur by practice, with 17 years’ experience in a broad spectrum of disciplines including product & technology, business, sales and marketing.

Petra Hoogendoorn is an industrial engineer, change manager and lead expert for ISO 82304-2 health and wellness apps – quality and reliability. This assignment from the European Commission went global in its cooperation with ISO and was published in July 2021. As part of the Commission’s Digital Single Market transformation of health and care strategy ISO 82304-2’s health app quality label and health app quality assessment aim to have digital tools and data contribute to patient-centred healthcare and citizen empowerment. Petra has been a patient advocate since her late husband was diagnosed with a brain tumor at age 38. She founded the ReMind cognitive rehabilitation app and the Goings-On what matters monitor app. ReMind is based on the award-winning neuropsychological research by Dr Karin Gehring and provides psycho education, alternative strategies, and an attention game. Goings-On enables cancer patients to monitor, within a minute a day, their individual life goal attainment and symptom burden. Goings-On further enhances decision making that not only matches tumor biology, but also addresses what matters most in the personal and working life of the person that carries the oppressive tumor. Petra does research at the National eHealth Living Lab, Leiden University Medical Center, The Netherlands.

George Afful serves as the Manager of ‘Med4All’ for the PharmAccess Group, Ghana. PharmAccess is a dynamic international non-profit organization with a digital agenda, dedicated to connecting more people to better healthcare in sub-Saharan Africa.  Med4All is one of PharmAccess’ newer and most promising initiatives, which leverages digital technology to strengthen the supply chain of medicines, with the aim of making quality medicines available to everyone in Ghana. In his role, George works closely with the Christian Health Association of Ghana (CHAG) to oversee the expansion of the digital supply chain platform.

George has over fifteen years of senior level experience in both public and private sectors in areas of Clinical Pharmacy and Public Health practice, Essential Medicines Management as well as Managerial Leadership.

He holds a Bachelor of Pharmacy and a Master of Clinical Pharmacy from Kwame Nkrumah University of Science and Technology in Ghana. He also holds a Master of Public Health from the Royal Tropical Institute in Amsterdam, the Netherlands. Among other qualifications, George has a certificate in Leadership Management in Health from the University of Washington (USA) and a certificate of Health Administration and Management, from the Ghana Institute of Management and Public Administration. 

Dr Loubna Bouarfa is a machine learning scientist turned entrepreneur. She is the founder and CEO of OKRA Technologies – an artificial intelligence data analytics company for healthcare. OKRA allows healthcare professionals to combine all their data in one place and generate actionable, evidence-based insights in real time, to save and improve human lives. Loubna is currently a member of the European Union High-Level Expert Group on Artificial Intelligence, where she is particularly focused on healthcare and achieving competitive business impact with AI. She was named an MIT Technology Review Top Innovator Under 35, a Forbes 50 Top Women In Tech, and won several prizes, including CEO of Year 2019 at the Cambridge Independent Science and Technology Awards and Best Female-Led Startup at the StartUp Europe Awards. On a personal level, she is a strong

advocate for diversity, women and challenging the status quo.

Chaith Kondragunta is the CEO of AIRAMatrix Pvt. Ltd based in Mumbai, India. AIRAMatrix develops and provides AI-powered solutions to the Life Sciences industry. The company’s solutions help improve workflow efficiency and increase accuracy in research labs, drug discovery studies and clinical diagnostics.

Chaith previously founded, grew and publicly listed AnalytixInsight Inc. AnalytixInsight is a Toronto based Big Data Analytics company that produces algorithmic driven analytics and informative content for leading financial institutions globally.

Prior to AnalytixInsight, he worked in corporate strategy and management consulting, including serving as the CEO of Stern Stewart Europe Ltd, a Corporate Finance and Strategy Consulting firm.

He has frequently written and spoken on corporate performance and analysis for several business media outlets including The Economist Group, CNBC and Bloomberg TV. He is also frequently contacted by media for topics related to AI and Data Analytics. He has a Bachelors in Electrical Engineering from NIT Warangal, Masters in Computer Engineering from the University of California, San Diego and an MBA from Carnegie Mellon University.

Multi-cultural, multi-disciplinary and multi-lingual is how Valerie can best be described. A real believer that great professional and personal interactions is the key to successful business relationships.

Prior to working in the Health Tech sector, Valerie was a senior banker for many years with BNP Paribas and very successfully led its business development efforts in parts of the Middle East.  She then carried on to work in the Start-up Nation with various entities in the different sectors, including Fintech, Cybertech, B2B platforms and digital health-tech.    

Her vast and broad experience as well as unique approach, has allowed her to contribute significantly to the dynamic expansion and profitability enhancement of the entities she has worked with.

Ritsaart is CEO at Incision and joined the company in 2017.

Ritsaart is a serial entrepreneur. He enjoys leading ventures where commercial success and positive impact go together. He founded the company NewMotion in 2009 and grew the company to be the largest network of charge points in Europe. Following this, Ritsaart co-founded ScaleUpNation, a growth accelerator for impact ventures with large scale-up potential. Earlier in his career, Ritsaart was partner at the hands-on investment firm H2 Equity Partners, worked as a strategy consultant at McKinsey & Company and worked at the M&A department of JP Morgan.

As a CEO, Ritsaart likes to use some of the ‘Rockefeller Habits’. So, he is very fond of Big Hairy Audacious Goals, morning huddles, quarterly rocks, core values, etcetera.

Florian is a Lead Data Scientist at Unit8 where he helps clients across various industries adopt and excel with data driven decision making. Before joining Unit8 he worked as a Data Science Consultant in Germany and London. He completed his PhD (Computational Chemistry) at the University of Cambridge in collaboration with the Cambridge Crystallographic Data Centre. As part of his research he also collaborated several pharmaceutical companies.

He is a strong believer in the open source community and has contributed to several projects as well as helping organize conferences and Meetups in Cambridge, London and Bonn.

Oliviana leads the development of EscherCloud’s community and ecosystem, including the launch of the AI Lab. Formerly Head of Community at Rockstart and ING’s open innovation district Cumulus Park, Oliviana has built and scaled communities across sectors successfully bringing startups, corporates, governments and talent together to collaboratively innovate.

Moses is the CEO of Computics Limited, who has combined his technology and communications expertise to manage and deliver a wide range of projects in healthcare, climate change and core technology.

Moses is currently consulting for the Africa Development Bank (AfDB) in a climate action project. He has spent the last 20 years professionally and as community service in communicating, promoting and advocating technology and healthcare.

Moses also acts as the Director, Marketing, Communication & Strategy of the Nigerian Healthcare Excellence Award (NHEA). Some of the healthcare projects he has been involved in includes, but is not limited to, data governance; privacy; PPP; CMEs; conferences & exhibitions; awards; and medical outreaches.

Moses is a cancer survivor who had Naso-Pharyngeal Carcinoma (NPC). Interestingly, his chemotherapy & radiotherapy were both done in Nigeria.

Dr. Andrea Biasiucci – is an Electronic and Biomedical engineer with a PhD in Brain-Machine Interfaces from the Swiss Federal Institute of Technology of Lausanne and more than 10 years of experience in medical device innovation and digital health. In his role at Confinis, he leads the Competence Cluster in Clinical Evaluation, Active Implantable Medical Devices and Digital Health. He has extensive experience in clinical evaluation and technical documentation for EU submissions of AI and Machine Learning projects.

Jan has a rich experience in scientific computing. Prior to OKRA, he worked as a senior consultant at SURFsara, the Dutch supercomputer centre. He also held research positions at various universities specialising in high throughput networking and computing. Jan holds an MSc in Bioinformatics from Delft University of Technology

Yahya was a senior scientist before joining OKRA, serving as the principal investigator of preclinical personalised medicine. He has over 12 years of experience in the healthcare sector and is the author of over 30 peer-reviewed scientific articles. Yahya holds a PhD in Medicine from Leiden University, and an MSc in Bioinformatics and Artificial Intelligence from Brunel University.

Milosz Wiciński is a Business Development Executive at Infermedica, a leading Artificial Intelligence health company that provides preliminary diagnosis and triage solutions. Milosz is passionate about technology, digital health, clinical decision support, and startups. In his work, Milosz works closely with health organizations, helping them create digital front door strategies in line with their product and financial objectives.

Bas has a multidisciplinary background combining clinical biochemistry and computer sciences. He has degrees in computer sciences, biology and life sciences and a PhD in glyco-bioinformatics. He is the head of life sciences at Omina Technologies. He is responsible for providing explainable, transparent and trustworthy AI to life sciences, pharma and healthcare.

In the past, he worked at contract research organizations in Oxford and Zagreb where he focussed on method development using laboratory automation and artificial intelligence. Additionally, he led various biomarker discovery projects.

Elyes Ben Mansour is founder & CEO of Epinest, eHealth IT solutions editor. He holds a Masters’ degree in Computer Sciences applied to companies Management. An IT Entrepreneur and now a Med Tech actor, since 2015 he has brough medical professionals and scientists around the start-up table to work on providing effective IT solutions to the eHealth market for the next generations.

Prof. Abderrahim El Moataz is a full-time Professor of computer science in the Computer Science Department of the University of Caen, in Normandy. His research concerns Partial differential Equations variational methods on graphs with applications in machine learning and Data Sciences.

Xpert AI (a spin-out start-up from Anderson Strategy) has developed a digital diagnostics platform which is able to model the human brain in order to diagnose neurological disorders. 

Justin also leads a team of digital strategy consultants at Anderson Strategy, a boutique strategy firm helping leaders realise value from digital innovation. He has developed digital strategies for 10 cities across the world looking at the social, health and economic benefits that can be realised by emerging technologies including 5G, AI & IOT. Justin has advised KPMG International on its global digital strategy and transformation and the digital programmes they deliver to their clients. He set-up the All Party Parliamentary Group on Artificial Intelligence to encourage debate on the impact of AI. He also sits on the BSI Innovation Committee developing standards for innovation.

Yoni has an interdisciplinary background with a formal education in neuroscience, biomedical science, economics, and artificial intelligence. With years of experience in operational and technical roles, he now wishes to bridge the gap between artificial intelligence, medical science, and clinical implementation of AI models. He obtained his master’s degree in AI at the University of Amsterdam in 2020. His thesis titled “Predicting DNA Damage Repair Deficiencies directly from H&E Whole-Slide Images using Deep Learning” was supervised by dr Jonas Teuwen, dr Hugo Horlings and dr Efstratios Gavves.

He is now a PhD candidate under the HISTO-AI project (2020-2024), with the aim to develop deep learning methods to predict genomic and transcriptomic information directly from H&E WSIs. The larger goal of this project is to predict which patient can benefit from immune therapy or targeted therapy, directly from commonly available H&E WSIs.

Yoni pitched the topic of his PhD for the 3MT (three minute thesis) competition, and won the UvA-wide finals. You can see the winning pitch here.

Senior director with over 20 years’ experience in building and implementing IT systems. A passionate believer that the time has come for AI to move from the research world and into the clinical working environment, thus assisting doctors and clinicians to transform the diagnosis and treatment of diseases through machine learning systems.

Yosef Safi Harb is the Founder and CEO at Happitech. With an Aerospace engineering background, he has 10 years of mechatronic / sensor design experience and holds 2 patents.  Happitech provides telehealth companies medical grade technology for monitoring heart rate and rhythm on a smartphone without additional devices. Happitech is helping to provide telehealth important vitals to the tele-health and medical professionals to help support those patients.

The technology has been validated and CE Certified & TGA Approved after undergoing clinical trials for the past three years at the largest Cardiology Hospital OLVG (Amsterdam).

Dedicated field: Research and Development; Capsule endoscopy patent main inventor; Capsule endoscopy experienced reader.
Detail dedicated field: AI applications in GI endoscopy
Domains of expertise: Gastroenterology; Capsule endoscopy; Coloproctology
High capability of bridging the gap between clinical needs and technological solutions. Capsule Endoscopy expertise in its main submodalities. Entrepreneurial soft skills and creative mindset.

Dr Suraj Kapa is the SVP of healthcare at TripleBlind. He practiced as a cardiac electrophysiologist at Mayo Clinic and over the course of his career he has published more than 200 peer-reviewed articles and book chapters, given 100s of invited lectures, and has filed over 30 patents resulting in startups and FDA approved technologies.

He is highly sought after for his views on the future of digital health and healthcare delivery, having advised multiple public companies and startups in digital strategy. Additionally, his work on digital tools to address the pandemic in 2020 and developing algorithms to enable early prediction of disease has been featured in major news outlets.

Antonio Russo leads Deloitte’s Analytics & Cognitive Advisory in Switzerland and is responsible for Innovation within Deloitte Switzerland’s Executive team. His team helps clients leverage the power of artificial intelligence and data to deliver more customer-centric and innovative products and services that catalyse growth and efficiencies.

He has over 20 years of experience in advising companies in large-scale global transformations, leveraging new delivery models (GBS/SSC, outsourcing) and innovative technologies (e.g. robotics, machine learning, natural language processing/generation). He helps global organisations review and implement new strategies for business support functions and deploy more effective and efficient services and governance models. Prior to joining Deloitte in April 2013, he held various sales and consulting leadership positions across Europe and was CEO of a start-up company developing brand protection technologies.

Yan has nearly 20 years of experience in the field of machine learning and artificial intelligence, with a focus on R&D, application, management and innovation. She has been the General Manager of Baidu Intelligent Healthcare since 2018. During her role, she has launched the brand “Ling Yi Zhi Hui (Chinese name:灵医智惠) “ with the vision of “Evidence-based AI empowers primary healthcare”.

Prior to joining Baidu, she was the Staff R&D engineer at Google in the U.S., where she started her career in 2005.

Yan graduated from Georgia Institute of Technology. Yan serves as the Vice Chairman of Intelligent Hospital and Artificial Intelligence Application Working Committee of Chinese Medical Information and big data Association (CHMIA). She also serves as a leading advisory expert of Peking University Medical Science and Technology Innovation Project.

Dr. Peter Lee is Corporate Vice President, Microsoft Healthcare. He leads an organization that works on technologies for better and more efficient healthcare, with a special focus on artificial intelligence and cloud computing. Dr. Lee has extensive experience in managing the process of going from basic research to commercial impact. Past illustrative examples include the deep neural networks for simultaneous language translation in Skype, next-generation IoT technologies, and innovative silicon and post-silicon computer architectures for Microsoft’s cloud. He also has a history of advancing more “out of the box” technical efforts, such as experimental under-sea datacenters, augmented-reality experiences for HoloLens and VR devices, digital storage in DNA, and social chatbots such as XiaoIce and Tay. Previously, as an Office Director at DARPA, he led efforts that created operational capabilities in advanced machine learning, crowdsourcing, and big-data analytics, such as the DARPA Network Challenge and Nexus 7. He was formerly the Head of Carnegie Mellon University’s computer science department. As a thought leader, he has spoken and written widely on technology trends and policies, spanning the fields of computing technology, healthcare, and innovation ecosystem. He is a member of the Boards of Directors of the Allen Institute for Artificial Intelligence and the Kaiser Permanente School of Medicine. He served on President’s Commission on Enhancing National Cybersecurity. He has led studies for the National Academies on the impact of federal research investments on economic growth and testified before the US House Science and Technology Committee and the US Senate Commerce Committee.

Toby Cosgrove, MD, is former CEO and president of Cleveland Clinic. Serving from 2004 through 2017, he led the $8 billion organization to new heights of achievement and efficiency, seeing it ranked the #2 hospital in America (U.S. News). He currently serves as Executive Advisor, working with Cleveland Clinic leadership on strategies for national and international growth.

Dr. Cosgrove graduated from Williams College and the University of Virginia School of Medicine. He trained at Massachusetts General Hospital and Brook General Hospital in London. In 1967, he was a surgeon in the U.S. Air Force, earning a Bronze Star.

Dr. Cosgrove joined Cleveland Clinic in 1975, and chaired the Department of Thoracic and Cardiovascular surgery from 1989 to 2004. He performed over 22,000 operations and earned an international reputation in valve repair He holds 30 patents for medical innovations. As CEO from 2004 to 2017, he reorganized services, improved outcomes and patient experience, and strengthened the organization’s finances.

He is a member of the National Academy of Medicine, and a Fellow of the National Academy of Inventors. In 2016, he was a Fortune Businessperson of the Year (No. 14). Three successive presidents of the United States have consulted him on healthcare issues.

Bernardo Mariano Junior is the Director of the Digital Health Department and the Chief Information Officer of WHO. He is responsible for setting and maintaining the vision and direction of WHO’s strategy of health in the digital age. As CIO, he ensures that the digital transformation of WHO enhances the organization’s collective performance and efficiency to deliver the ‘Health for all’ global development agenda.

Prior to joining WHO, Mr. Mariano held senior managerial positions in the International Organization for Migration as Senior Regional Adviser for Sub-Saharan Africa in the office of the Director-General, Chief Information Officer/Director, Information & Communications Technology, and Regional Director for East and Southern Africa.

Trained as a nutritionist, Faculty of Nutrition and Food Sciences, Porto University; Master’s in Public Health, London School of Hygiene and Tropical Medicine. Formerly: worked at national level on developing and implementing health promotion policies with the Ministry of Health in Portugal and the Institute of Preventive Medicine of the University of Lisbon; worked with the World Health Organization Headquarters on global guidelines and policy development for noncommunicable diseases.

Currently, Head of System Initiative on Shaping the Future of Health and Healthcare and Member of the Executive Committee, World Economic Forum. The System Initiative on Shaping the Future of Health and Healthcare provides a dynamic platform for leading businesses, governments, civil society organizations and world-class experts to shape the global health agenda; co-design and accelerate the implementation of collaborative approaches that transform the health ecosystem – across prevention, diagnosis, treatment, cure and maintenance of health; and ultimately enables populations to live healthier lives and have access to the care they need when they need it.

Dr. Abnousi is the Head of Health Technology at Facebook and a practicing Interventional Cardiologist. He also serves as Innovation Advisor to the American College of Cardiology, Professor Adjunct at Stanford University School of Medicine, and Assistant Professor Adjunct at Yale University School of Medicine. He has previously led innovative healthcare efforts at companies such as McKinsey and Google, and has served as Founder and CMO of CorDynamix Inc., an interventional heart failure company. He completed Fellowships in Cardiovascular Medicine and Interventional Cardiology, as well as Residency in Internal Medicine at Stanford University Medical Center. He was previously a resident surgeon at the University of California, San Francisco. He completed his MD at Stanford University School of Medicine, MBA from Oxford University, and MSc in Health Policy, Planning, & Financing from the London School of Economics. 

Kimberly Powell is vice president of healthcare at NVIDIA, where she leads the company’s efforts to build healthcare computing platforms that address grand challenges like early detection, diagnoses and personalized treatment.

Partnering with healthcare researchers, startups and industry leaders, her mission is to accelerate the adoption of advanced computing technologies like GPU computing and artificial intelligence.

Powell joined NVIDIA in 2008 as the global business development manager for healthcare. She also served as senior director of AI business development. Prior to joining NVIDIA, she was a product manager for diagnostic imaging at Planar Systems and a hardware engineer at DOME Imaging Systems doing FPGA design.

Powell has a Bachelor of Science from Northeastern University in electrical engineering with a concentration in computer engineering.

First and foremost, John is a thinker. A thinker entrenched in the world of science, medicine and innovation. John is the founder of NOSTALAB—a digital health think tank. He’s generally regarded as one of the top global strategic and creative thinkers in this important and expanding area. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future of health innovation.

Unwilling to accept the status quo, he’s a contrarian with a focus the future of health and wellness. A leading voice in the convergence of technology and health, Nosta helps define, dissect and deliberate global trends in digital health. He is consistently ranked among the top names in almost every digital list and has sustained that position for several years. Beyond simply an influencer, John is also defined as “most admired” to “top disruptor” in digital health, life sciences and the pharmaceutical industry. He is also a member of the Google Health Advisory Board and has penned HEALTH CRITICAL for Forbes–a top global blog on health and technology.

John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of advertising,” a process where strategy and creativity work together for superior marketing. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to consumers, clinicians and scientists. Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology with a focus on acute myocardial infarction, ventricular arrhythmias and sudden cardiac death.

John cut his teeth at the “big” agencies including Ogilvy CommonHealth, where he has held a series of positions including Chief Creative Officer, Chief Strategic Officer and unit President.

Dr. Moore leads Microsoft’s Health efforts globally and is responsible for product strategy, product development, and research including AI and machine learning technology for healthcare and life sciences. He is also Microsoft’s senior executive leading dedicated research and development collaborations with Microsoft’s strategic alliance partners in this domain with the goal of enabling a more open, interoperable, and AI-infused foundation for healthcare delivery that aspires to enable access to healthcare for all globally.

Greg is an engineer (MIT PhD), practicing neuroradiologist, clinical informaticist, neuroscientist, and innovator experienced in assembling and inspiring highly talented teams to positively transform healthcare for the benefit of humankind. Prior to joining Microsoft, Greg was Vice President Google Inc, Google Cloud Healthcare & Life Sciences and founder of the healthcare vertical for Google Cloud. Prior to his leadership appointment at Google, he was Chief Emerging Technology and Informatics Officer at Geisinger Health System where he also was Director of the Institute for Advanced Application and served as Interim Chair of System Radiology. His prior appointments include Los Alamos National Laboratory (University of California), Wayne State University School of Medicine, Children’s Hospital of Michigan and Penn State University Hershey Medical Center where he was a tenured Professor in the College of Medicine. Greg currently serves on the board Hillrom Inc, and is an Adjunct Clinical Professor of Radiology at Stanford University School of Medicine.

Moore is board certified in Diagnostic Radiology, Neuroradiology and Clinical Informatics and holds degrees from North Park College-Chicago (BS), Massachusetts Institute of Technology (SM-Nuclear Engineering and PhD-Radiological Sciences), and Wayne State University School of Medicine (MD-Doctor of Medicine) and completed residency in Diagnostic Radiology and a fellowship in Neuroradiology, both at Penn State University Hershey Medical Center.

The Novartis Foundation focuses on innovating health and care for low-income populations, driven by data, digital and AI. Ann chairs the Broadband Commission for Sustainable Development Working Group on Digital Health, is a member of the International Advisory Board of the Commonwealth Centre for Digital Health. Ann served as a member of the US National Academies of Science Engineering and Medicine Committee on Improving the Quality of Health Care Globally and currently sits on the US National Academies of Medicine Commission on Healthy Longevity.

Before leading the Novartis Foundation, Ann was Franchise Medical Director Critical Care for Novartis Pharma in Basel and Therapeutic Area Head Cardiovascular and Metabolism for Novartis Pharma Belgium. 

Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium and as Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva. She has also worked as Health Coordinator for the ICRC in several countries.

Ann holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, as well as a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium. 

Bakul Patel is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA).  Mr. Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information technology. This includes responsibilities for mobile health, health information technology, cyber security, medical device interoperability, and medical device software. 
 

Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort.

Before joining FDA, Mr. Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fastpaced, technology-intensive organizations.
 

Mr. Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University.

Dr. Sema Sgaier leads Surgo Foundation’s strategy, operations, and partner relations. She works at the intersection of behavior, data, and technology, drawing on her extensive experience in policy, strategy, and management of development programs.  Sema has led several large-scale programs, as well as research and evaluation projects, and has worked with governments in India and Africa on public-health policy and large-scale delivery. 

Prior to joining Surgo Foundation, Sema held several roles at the Bill & Melinda Gates Foundation. She led a portfolio on voluntary medical male circumcision for HIV prevention across eastern and southern Africa. As part of the India Country Office, Sema led the scale-up of the foundation’s HIV prevention program (Avahan) in several states, managed its transition to the government of India, and developed data platforms for decision-making. 

Before joining the Gates Foundation, Sema was a neuroscience and genomics scholar at Harvard Medical School and a fellow with the Centre for Global Health Research. She is an Assistant Adjunct Professor at the Harvard T.H. Chan School of Public Health and an Affiliate Assistant Professor, Global Health at the University of Washington. She also serves on the board of the Bill & Melinda Gates Foundation’s Alumni Network. Sema was selected as a Rising Talent by the Women’s Forum for the Economy and Society.  

Sema received her PhD in cellular and molecular biology (developmental genetics) from New York University, her MA in neuroscience from Brown University, and a BSc in molecular biology and genetics from Boğaziçi University (Istanbul).   

Head of IBM Watson Health for Europe, Middle East & Africa. As the Managing Director, Mark holds full responsibility for the Sales & Go to Market strategy & team, for Watson Health software products and solutions to their customers. This includes the full portfolio of Life Sciences, Oncology, Genomics, Imaging, Government, Value-Based Care & Population Health Management solutions.

Mark has a clinical background and has worked in the NHS as well as many senior leadership positions in global, European and start-up healthcare companies throughout his career, with over 25 years of experience in the healthcare segment, Mark brings a wealth of experience and perspective and he is passionate about health and social care for everyone.

Gary Marcus, scientist, bestselling author, and entrepreneur, was CEO and Founder of the machine-learning startup Geometric Intelligence, recently acquired by Uber, and is known for his provocative and bold claims in artificial intelligence, neuroscience, and cognitive science. Trained by Steven Pinker, he received his PhD at MIT at age 23. His professional research, published in leading journals such as Science, Nature, Cognition, and Artificial Intelligence, has focused on the foundations of cognition in humans, animals and machines, spanning fields from developmental psychology to neuroscience to genetics to artificial intelligence. A special interest has been on the challenge of endowing machines with common sense.

He is also well-known for his writing for the general public, including frequent essays and op-eds for The New Yorker and The New York Times. His books include The Algebraic Mind, The Birth of the Mind, Kluge: The Haphazard Evolution of the Human Mind, The New York Times Bestseller, Guitar Zero and The Future of the Brain: Essays By The World’s Leading Neuroscientists.

In a 2012 essay for The New Yorker, he was perhaps the first person to publicly criticize deep learning, drawing on arguments he developed in his 2001 technical book The Algebraic Mind. More recently, in a 2018 arXiv article, Deep Learning: A Critical Appraisal, he asked whether deep learning might be “approaching a wall.” The challenges he laid out there were covered everywhere from The
New York Times to Wired to The Financial Times and Wall Street Journal.

In another provocative 2012 essay, Moral Machines, Marcus was the first to adapt “trolley problems” to driverless cars, anticipating much recent research on the ethics of AI. His next book, REBOOT: Getting to AI We Can Trust, to be published by Pantheon in Fall 2019, co-authored with Ernie Davis, calls for a fundamental rethinking of current approaches to artificial intelligence.

Bertrand Bodson has been Chief Digital Officer of Novartis since January 1, 2018. He is a member of the Executive Committee of Novartis.

From 2013 to 2017, Mr. Bodson served as Chief Digital and Marketing Officer of Sainsbury’s Argos, where he led Argos’ successful transformation from a traditional catalogue business to the third-largest online retailer in the United Kingdom.

Prior to that, he was Executive Vice President of the global digital business at EMI Music from 2010 to 2013. He co-founded Bragster.com, a social networking and content sharing website, and has also held senior roles at Amazon.

Mr. Bodson earned a Master of Business Administration from Harvard Business School in the United States, where he was a Baker Scholar, and a master’s degree in commercial engineering from the Solvay Business School (Belgium)/McGill University (Canada). He is a member of the Board of Directors of Electrocomponents PLC.

Ramya Palacholla is a Physician and one of the Lead Scientists at Partners Healthcare Pivot Labs. She is also a faculty member of the Harvard Medical School. Currently, Dr. Palacholla works with a multidisciplinary team that develops and executes digital health strategy and research projects in collaboration with top pharmaceutical, research and medical technology companies. She is passionate about her research focused on validation of innovative health technology solutions for improving patient lives. Dr. Palacholla has published her work in several health care journals and presented her research on innovative technologies on international platforms such as the World Economic Forum (also presented at the G8 Summit), served as a reviewer for health technology journals, and spoken at national conferences as a thought leader in the field of health care research and innovation. Her cutting edge research in this area is recognized for its high caliber, and she continues to advance this field to new frontiers. Dr. Palacholla’s idea on an “Innovative Tumor Response Forecasting Model in Breast Cancer Patients” was awarded the first position in the Harvard Ideation Challenge among hundreds of submissions received from across the country. Furthermore, the idea was also selected as one of the top six finalists for the Boston Scientific and Google Connected Patient Challenge, 2018, which is unquestionably a renowned platform that showcases healthcare innovations across the globe. She was also a co-author of one of the first books to be written on proven treatment methods for the management of Military Sexual Trauma and PTSD in war veterans. Following these successes, Dr. Palacholla’s research is well-known in the healthcare innovation space and has given her opportunities to present her research work at national healthcare conferences and summits.

Weihong Huang received the B.Eng. degree in automation and M.Eng. degree in pattern recognition and smart control from Southeast University China in 1995 and 1998 respectively and the Ph.D. degree in computer science from Nanjing University China in 2001. From 2001 to 2002, he was a Post-doctoral Research Fellow with the CNRS University Lyon 1 France. From 2002 to 2005, he was a lecturer with the Department of Computer Science, University of Hull, United Kingdom. From 2005 to 2014, he was a senior lecturer with School of Computer and Information Systems, Kingston University London, United Kingdom. Since 2016, he was appointed as a professor and the Depute Director of the Mobile Health Ministry of Education – China Mobile Joint Laboratory, Xiangya Hospital Central South University, China. His research interests include mobile health, artificial intelligence in healthcare, cognitive computing for healthcare, semantic multimedia computing and knowledge graph applications. Prof. Huang is a committee member of China Hospital Information Management Association, standing committee member of the Medical and Health Big Data Evaluation and Assurance board of the Chinese Health Information and Big Data Association, chairman of specialized committee of information management of Hunan Health Management Association.

Anne is the global Industry Senior Managing Director for Accenture’s Life Sciences business and a global client lead.  She has been with Accenture for 28 years.  Over this period she has worked across the US, Europe and Asia with global companies transforming their business and operating models, to meet changing market and portfolio needs.  She has been in China since 2007 and has been on the board of the global Products Operating Group of Accenture since 2006.  She has published numerous articles over the past 20+ years. Her most recent publication is a book entitled ‘Healthcare Disrupted: Next Generation Business Models and Strategies@ (Wiley Feb 2016)”.   Based in Hong Kong, Ms. O’Riordan is a member of The Women’s Foundation, the 30% Club and co-chair of the Women of Influence Committee at the American Chamber of Commerce.

Asif Jan leads a multidisciplinary team of scientists specializing in computer science, neuroscience, and statistics. The team implements a variety of statistical and machine learning methods on real-world datasets (e.g. electronic medical records, health insurance claims, disease registries) to fulfill evidence and data analysis needs of the Neuroscience disease area at Roche. Previously, he was Head of Data Science at Roche Diagnostics leading a team of quantitative scientists supporting in vitro diagnostics and clinical decision support product development, where he defined data strategy enabling the use of real-world data. Earlier he has had a number of roles overseeing technology strategy development, enterprise and solution architecture, and program management at Roche and in other research organizations. Asif has vast experience of building and leading data science teams in pharma and diagnostics companies, and industrial research institutes, tackling complex scientific and business problems. He strongly believes that the intersection of strategy, technology and data science is needed to fight diseases, thereby enabling better care for everyone.

Asif holds a PhD in Neuroscience (informatics) from the Swiss Federal Institutes of Technology Lausanne (EPFL), Switzerland, and an MPhil in Computer Science from the University of the West of England, Bristol, UK.

Dr. Alessandro Curioni is an IBM Fellow, Vice President of IBM Europe and director of the IBM Research Lab in Zurich, Switzerland. He was also recently appointed as the Watson IoT Research Relationship Executive.

Dr. Curioni is an internationally recognized leader in the area of high-performance computing and computational science, where his innovative thinking and seminal contributions have helped solve some of the most complex scientific and technological problems in healthcare, aerospace, consumer goods and electronics. He was a member of the winning team recognized with the prestigious Gordon Bell Prize in 2013 and 2015.

Dr. Curioni received his undergraduate degree in Theoretical Chemistry and his PhD from Scuola Normale Superiore, Pisa, Italy. He started at IBM Research – Zurich as a PhD student in 1993 before officially joining as a research staff member in 1998. His most recent position was Head of the Cognitive Computing and Computational Sciences department.

Dr Natalie Banner is the Lead for Understanding Patient Data (UPD), an initiative hosted at the Wellcome Trust to support better conversations about how patient data is used for care and research. UPD works with patients, charities and health professionals to champion responsible uses of data, feeding into policy development, creating accessible resources and horizon scanning for emerging issues that may affect public confidence in the use of health data.

This includes exploring emerging data-driven technologies and how to create the right ethical and governance frameworks for these in healthcare and research. Natalie formerly led Wellcome’s policy work on GDPR and data protection, seeking to ensure UK legislation and regulation creates a supportive, trustworthy environment for health research using patient and health-related data. She was recently named in BioBeat’s “50 Movers and Shakers in BioBusiness” for 2018.

Roland Rott is the global General Manager of Women´s Health Ultrasound at GE Healthcare, the market leader of Ultrasound for Obstetrics/Gynecology worldwide. The Voluson product line for Women´s Health has been pioneering Ultrasound and AI technology and is touching more than 250 million lives globally every year.

Roland leads the global product organization, consisting of clinical and product management, research & development, installed base customer service, quality management and is responsible for innovation and manufacturing sites in Austria, Germany and Korea.

Before joining GE in 2011, Roland was Managing Director EMEA and Executive board member of Exact Software – a midcap public company headquartered in the Netherlands – leading 4 R&D teams and subsidiaries in 20 countries spanning over Europe/Middle/East, Africa & Asia. In his early career, Roland had an entrepreneurial start, founded two software companies in Austria and successfully sold those to strategic investors.

Roland has a software engineering background, studied International business administration and took executive education courses on strategy and Innovation in Stanford University and the London Business school. He is based in Vienna, Austria and lives there with his wife, two teenage kids and a toddler.

Stephanie is a health technology advisor in digital health and artificial intelligence.  She has over 15 years clinical and research experience and trained and worked in the NHS as a surgical oncologist specialising in women’s cancers.

Stephanie is an advisor and consultant in Clinical AI at the World Health Organisation’s Department of Digital Health & Innovation.  She is the Healthcare Lead for Women in AI (WAI), an NHS England Clinical Entrepreneur and Honorary Senior Research Fellow at UCL where she was awarded a Doctorate in Clinical Research.

During her clinical career she sat on council of a national cancer society (BGCS) and was awarded numerous International travelling fellowships to; Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France.

Stephanie is a regular speaker on validation of health technology and has hosted a US podcast (HLTH) on themes around technology and the future of health.

Salvatore Scalzo has been working for more than seven years in the European Commission. Since November 2013, he is Policy and Legal Officer in the Unit dealing with legislation on medical devices (currently unit D4 of the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs). After having dealt with the negotiations of the proposed new Regulations on medical devices which were adopted in spring 2017, he is currently working on the legal interpretation and implementation of those Regulations and coordinating, among other tasks, the activities of the European Commission Expert Groups on medical device identification and traceability and medical software. 

Amir Saffari has a PhD in Machine Learning and has been working in the field of Artificial Intelligence for more than 17 years, researching and developing ML theory, applications, and products. He’s numerous publications in top-tier ML conferences and journals and most of his research has been released as open source software. He was part of Sony’s R&D team and has been involved in a few ML startups prior to joining BenevolentAI where he is currently leading the research and development of ML technology to drug discovery.

Daniel is a serial entrepreneur with 20 years’ experience in strategic growth and transformational change. During his career, he’s founded several startups around the world and served as general counsel and managing director at various tech firms across the UK, US, Denmark and Germany. Daniel was a consultant at the Boston Consulting Group and studied law as a Fulbright Scholar at the University of Houston. He holds an MBA from the University of Chicago. 

Chris Gibson, PhD, is the Co-Founder and CEO of Recursion Pharmaceuticals, a biotech company leveraging the latest in automation, artificial intelligence and biology to do drug discovery at scale. Chris developed the technology and approach underlying Recursion as part of his MD/PhD graduate work in the lab of Co-Founder Dr. Dean Li at the University of Utah. Chris left medical school to transform this technology into the rapidly growing company it is today. Chris is a graduate of Rice University with degrees in bioengineering and managerial studies, as well as a graduate of an intense entrepreneurship course at Stanford GSB. He is a Board Member of CureHHT, a patient advocacy group for Hereditary Hemorrhagic Telangiectasia, and a member of the Rare and Undiagnosed Network Advisory Board. Outside of work, Chris enjoys cycling on both the road and the trails that cut through Utah’s great wilderness, as well as spending time with family.

He was named top-20 Portuguese world changer and he is a leading expert in the real-world application of Advanced Analytics & Machine Learning to Hospital problems, transforming sparse patient’s BigData into actionable clinical insights. His team built one of the most outstanding Hospital Big Data platforms currently working in EU hospitals. This platform behaves like a “Data Robot” that captures and analyses 560 billion patient data points\minute, coming from 30 different systems, to predict and signal at-risk patients for clinical deterioration up to 7 days in advance. This work has received some of the highest in the industry, amongst which the 1st prize in the HIMSS Europe Digital Healthcare 2016 Award (Barcelona), the 1st prize in the “2014 Microsoft Worldwide Health Innovation Award (MSHUG)” (Orlando, USA) and the 2014 “Big Data & Analytics Solution of the Year” prize by IT Europa (London, UK).

Dr. Chander is a physician, neuroscientist, and futurist who trained at Harvard, UCSD, UCSF, and the Salk Institute. She is Chair of Neuroscience and Faculty of Medicine at Singularity University, Visiting Scholar in Medicine at Stanford (where she was on faculty for 8 years), and Senior Non-Resident Fellow at the Atlantic Council GeoTech Center. She has also co-founded and leads 2 companies during the pandemic – Lucidify, a tele-neuroICU platform, and Plexxus, a company building the world’s connected global immune system. Dr. Chander also serves on a NASA-White House task force for COVID19, and both co-chairs and directs the post-pandemic global health initiative for OneShared.World. Her research interests center around mapping human consciousness, how consciousness will be altered by human augmentation, and how mapping consciousness in humans may enable us to recognize it in non-human, intelligent beings (both on and off-planet). In 2004, she was a finalist for astronaut selection, and has since maintained a passion for building medical systems in space to sustain human exploration.

Junaid is the Chief Medical Scientist at Microsoft Research and a practising physician in the NHS (the UK’s National Health Service). He was previously the Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Sharp & Dohme, where he led a range of strategic initiatives to improve patient care, including establishment of internal partnerships across the enterprise and external partnerships across the health care ecosystem. He cofounded “VelocityHealth” as Europe’s first prevention focused digital-health accelerator, in partnership with Telefonica, and led his team to deliver the “NHS Testbed” in partnership with Verily Life Sciences (part of Alphabet), which the Health Service Journal recognized as the “Best Pharmaceutical Partnership with the NHS” in 2018.

Previously, Junaid has worked across primary care, secondary care, and public health settings in addition to acting as a payer, and policy maker within the UK, where he specialized in informatics, digital transformation, and leadership. He has consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Junaid completed his MBA at the Imperial College Business School in London and has studied health strategy and quality improvement at both Harvard and the Institute of Healthcare Improvement in Boston. Academically, he is a Clinical Associate Professor at UCL (University College London), and Visiting Scientist at the Harvard School of Public Health.

Junaid hopes to bring his clinical, life sciences, and academic experiences together in this new role. He hopes to help healthcare focused teams across Microsoft, unlock the power of technology to help solve the healthcare challenges of today, whilst reimagining a better future for tomorrow.

Ramatoulie is a Public Health Consultant and Health Communications Specialist. She holds an MPH in Community Health Promotion, with an interdisciplinary concentration in Global Health, from the University of Minnesota, USA. Ramatoulie is a Connector and Administrator for the Pan African Women in Health (PAWH) virtual platform which creates a space for African women health professionals to connect and provide or receive mentorship.

Presently, she works as a Stigma Index Researcher with the Global Network for People living with HIV (GNP+). Previously, she served as an Epidemiologist, with the US Centers for Disease Control and Prevention, conducting surveillance of the West Africa Ebola outbreak in Guinea and providing technical assistance to the Ministry of Health and to the Expanded Program of Immunization’s supplemental immunization activities for polio eradication. Prior to joining CDC, she conducted HIV/AIDS research in Kigali, Rwanda, as a Global Health Corps fellow, and worked as an HIV/AIDS Medical Case Manager in Minnesota, USA. As a Consultant, she has worked on a variety of projects related to women’s empowerment and the demographic dividend in the Sahel as well as on youth access projects and family planning services in Senegal. Ramatoulie is an avid mentor and an advocate for girls and women’s sexual and reproductive health rights. She is also a member of Scientists of the Gambia, Paradise Foundation’s COVID-19 Coordination team, and EyeToo; initiatives founded by young Gambians, both in the diaspora and at home, to encourage more youth to pursue STEM careers, improve health messaging around COVID-19, and to address accessibility and affordability of vision care in The Gambia, respectively. She is presently based in Yaoundé, Cameroon.

As highly skilled assessor and quality improvement facilitator, Bonifacia Benefo Agyei works passionately with healthcare facilities to support improvement in healthcare quality and patient safety using her rich experience in healthcare system management from both public and private sectors. Bonifacia advocates for healthcare quality improvement in Ghana using international quality standards and digital innovations. 

Bonifacia has been working at PharmAccess since 2012 where she currently leads and manages the entire SafeCare Program and other quality related programs provided by PharmAccess Ghana. Among others, this includes directing and coordinating all quality and technical services, while collaborating with public and private partners to support the institutionalization of quality improvement and the digitalization of healthcare in Ghana. She has a range of healthcare management experience, in quality improvement, business development as well as in the development and roll-out of digital innovations.

Prior to joining PharmAccess, she served as Accreditation Quality Officer and Clinical at the National Health Insurance Authority (NHIA), Ghana after almost ten years of experience serving in various nurse management roles and responsibilities in public and private health facilities. She also has extensive experience in training, mentoring, development of quality standards, manuals and curriculum; such as for the novel maternal healthcare franchise network (Woman360) in Ghana. Among other qualifications, Bonifacia holds a bachelor’s degree in nursing, a master’s degree in public administration and is a Fellow in the International Society for Quality in Health Care program (ISQua).

Luciano Floridi is the OII’s Professor of Philosophy and Ethics of Information at the University of Oxford, where he is also the Director of the Digital Ethics Lab of the Oxford Internet Institute. Still in Oxford, he is a Distinguished Research Fellow of the Uehiro Centre for Practical Ethics of the Faculty of Philosophy, and Research Associate and Fellow in Information Policy of the Department of Computer Science. Outside Oxford, he is Faculty Fellow of the Alan Turing Institute (the national institute for data science) and Chair of its Data Ethics Group; and Adjunct Professor (“Distinguished Scholar in Residence”) of the Department of Economics, American University, Washington D.C.

His research concerns primarily Information and Computer Ethics (aka Digital Ethics), the Philosophy of Information, and the Philosophy of Technology. Other research interests include Epistemology, Philosophy of Logic, and the History and Philosophy of Scepticism. He has published over 150 papers in these areas, in many anthologies and peer-reviewed journals.

Marcel Salathé is a digital epidemiologist working at the interface of population biology, computational sciences, and the social sciences. He obtained his PhD at ETH Zurich and spent two years as a postdoc in Stanford before joining the faculty at Penn State in 2010 at the Center for Infectious Disease Dynamics. In 2014, he spent half a year at Stanford as visiting assistant professor. In the summer of 2015, Marcel became an Associate Professor at EPFL where he heads the Digital Epidemiology Lab at the new Campus Biotech. In 2016, he has also been appointed Academic Director of EPFL Extension School, whose mission is to provide high quality online education in digital technology.

Hila leads our Global Health Initiative to improve access to healthcare in resource-limited countries. Before Ada, Hila was a founding member and Head of Academics at Kiron Open Higher Education. She is a Digital Female Leader Award recipient, an MIT Solve Member, and a talented public speaker (TEDx, Clinton Global Initiative, UNESCO NGO Forum). “I am dedicated to using technology for social good.”

Alison is a clinical research psychologist and health tech visionary dedicated to creating smart, scalable and accessible mental healthcare solutions. Her work to explore how digital treatments can help solve human problems began more than 20 years ago, when she created one of the first online support groups for people with eating disorders.

That work led to PhD level studies in psychology at University College Dublin and post-doctoral training at Stanford School of Medicine and with the American Psychiatric Association. At Stanford, Alison also worked with AI pioneer Andrew Ng to explore the intersection of AI and healthcare, leading his Health Innovation Lab in Computer Science.

A frequent speaker on digital therapeutics design and development, barriers to care, and engagement, Alison has authored more than 40 publications and been awarded research grants and contracts from the NIH, the Davis Foundation and APA. She is also currently an Adjunct Lecturer in the Psychiatry and Behavioral Sciences Department of Stanford’s School of Medicine. Alison holds a PhD, an MLitt and a Bachelor of Arts degree in psychology from University College Dublin.

João works in the design and implementation of ST&I policy in the State of São Paulo and has previously worked with innovative entrepreneurship and international cooperation at the Maranhão Foundation for Research, Science and Technology Development – FAPEMA, through Vetor Brasil’s Public Sector Trainee Program, which develop young professionals in their careers in local and state governments in Brazil. João holds a Bachelor’s degree in International Relations – Federal University of Rio Grande do Sul and a M.A. in International Political Economy – Federal University of Rio de Janeiro.

Andre gained a BSc degree in Surgical Technology and graduated from Imperial College School of Medicine in 2004. He began his surgical training at St. Mary’s Hospital in London and in 2006 became a full member of the Royal College of Surgeons.  In 2008 he was awarded one of three places as an Academic Clinical Fellow, and in 2009 was appointed a Clinical Innovation Fellow at Imperial College London. In 2010 he was awarded a prestigious Welcome Trust Research Fellowship to pursue research in the fields of stem cell technology & biomaterials, and completed his PhD at Imperial College in 2012.  Andre has over 30 peer-reviewed journal publications to his name and has also authored several book chapters. He has been an invited speaker at international surgical conferences on the subject of surgical quality assessment, and regularly presents on medical entrepreneurship and surgical training.

Jay Mandrekar, Ph.D., is the primary statistician for the Mayo Clinic Department of Neurology, and the Divisions of Infectious Diseases and Clinical Microbiology. He is involved in multiple clinical trials, population-based studies and research grants in these areas.

Dr. Mandrekar’s primary research interest is in the application and extension of statistical methods for the evaluation of the quality and domains of clinical teaching, multiple sclerosis and other neurologic diseases, prosthetic joint infections, and assays for viral detection.

Rachel Sibande is Program Director, Data for Development at the Digital Impact Alliance, a unit within the United Nations Foundation. She leads sector wide Big data for development models across countries in Africa, supporting Governments to leverage the power of Big data for decision making. Recently, Rachel has led the development of risk and epidemiology models for COVID19 that integrate mobility metrics generated from Mobile Network Operator data and Geospatial data. The models would help Governments understand where to anticipate COVID19 hotspots, stock outs and health facility burden prior. These Big Data models have been developed for Malawi and 14 other West African Countries under the West African Health Organisation regional block. Rachel is  also leading on the integration of geospatial data, mobile network operator data and immunisation data to enhance immunisation outcomes in Tanzania.She has also led the development of resources used by practitioners in the big  data for development space to get started deploying similar initiatives. Her work cuts across a new space in the Big Data and AI space as it seeks to  integrate traditional digital health data and non traditional data sets such as mobile network operator data  largely to help understand mobility patterns of people and how they impact health outcomes.

Dániel is the creator of the first compartmentalized protein-protein interaction database, with years of experience building computational models in order to understand the behaviour of human cells. As a medical doctor, Daniel translates computational results into clinical interpretations, indispensable to design innovative and relevant treatments to defeat cancer.

A clinician by training, Charlie is Freenome’s Chief Partnership Officer, focusing on mid- and longer-term relationships that will help define the company’s future directions and revenues and works closely with the business development team in managing corporate client accounts and institutional collaborations. Prior to co-founding Freenome, Charlie co-founded a company that uses circulating cell-free (cf)DNA from maternal blood samples to diagnose chromosomal abnormalities during pregnancy. The resulting in-vitro diagnostic, IONA, has been marketed successfully across Europe and the Middle East. Charlie studied medicine and neuropsychology in the UK, earning a Masters degree from Oxford with a focus on immunotherapy. He has worked in some of the UK’s leading oncology centers, including the Royal Marsden.

Eyal Toledano is co-founder and CTO of Zebra Medical Vision; Eyal focuses on innovation in medical imaging machine vision. Graduated with Master of Science from the MIT Media Lab. Eyal served for more than 8 years as the CTO and Advanced Technology GM for Samsung Israel R&D (STRI/Yakum). Before co-founding the Israeli R&D of Samsung Eyal was leading the development of challenging projects at Sun Microsystems. Eyal completed 7 years of military service in the IDF Elite Intelligence Technologies. Eyal still hacks code every day and enjoys making morning sandwiches.

Magnus Conteh joined the Last Mile Health team in 2018 to help lead the Community Health Academy, which aims to reinvent the education of community health workers – and the health system leaders who support them – for the digital age.

Magnus brings over 25 years of senior level experience in education, global health, and digital health to Last Mile Health. Previously, Magnus worked for seven years at World Vision Ireland, most recently serving as the Deputy CEO/Director of Programmes and Strategy. Notably, he led World Vision’s involvement in the Johnson & Johnson/Janssen Ebola Vaccine trial in Sierra Leone, which included overseeing the deployment of technology critical for the clinical trial. In addition to serving as a member of the World Vision International Digital Health Steering Committee, he forged multi-stakeholder collaboratives and digital health partnerships with a number of governments, mobile network operators, and other INGOs in Africa.Prior to joining World Vision Ireland, he held a number of senior management positions in the National Health Service in the UK and the Health Service Executive in Ireland, where he served as Director for the Regional Centre of Nursing/Midwifery Education at the University Hospital in Galway. Magnus holds a Masters of Health Science (Hons) in Health Services Research from the National University of Ireland, Masters of Arts in Health Service Policy and Management from Brunel University (UK), and a Postgraduate Diploma in Management Studies from Kingston Business School at Kingston University (UK).

Jon Sorenson, Ph.D., is head of the cheminformatics team at Atomwise. Jon has nearly 20 years of experience in computational biology and software leadership, ranging from senior contributor roles to executive management of 100+ person teams spanning computational biology and software operations. He has held senior leadership roles at Applied Biosystems, Pacific Biosciences, Invitae and 10X Genomics, and he is co-author on more than 30 publications and patents. At Atomwise, Jon is thrilled to have returned to his first passion of computational drug design, a field that he first encountered as a college intern working at Merck Research. Before joining industry in 2000, he obtained a Bachelor of Science in chemistry and mathematics from Harvey Mudd College, a Master of Philosophy in theoretical chemistry from the University of Cambridge and a Doctor of Philosophy in computational chemistry from the University of California, Berkeley.

Dr. Manuel García-Herranz is Chief Scientist at UNICEF’s Office of Innovation and Information and Communications Technology Division joint initiative on Big Data and Artificial Intelligence. He has been working with UNICEF for more than 6 years to bridge the gap between Data Science and the needs of the most vulnerable children. At UNICEF, he co-created the MagicBox program to build research and partnerships that can transform Big Data and Artificial Intelligence into equitable tools to better respond to epidemics or natural disasters and deliver results to the most vulnerable populations. Through the Science team, UNICEF Innovation has also been focusing on the future of digital vulnerabilities, working to identify and curve emerging computational inequalities such as bias in new sources of data and unfairness in algorithms. Manuel holds a PhD in computer science from the Universidad Autonoma de Madrid.

Dr. Oliver Morgan is the Director of the Health Emergency Information and Risk Assessment Department in the WHO Health Emergencies Program. From 2007 through 2016, Dr. Morgan worked for the US Centers for Disease Control and Prevention during which time he held critical leadership positions in the Ebola response between November 2014 and February 2016 (CDC Atlanta Ebola Response Incident Manger and CDC Country Director in Sierra Leone).From March 2010 to October 2014, Dr. Morgan was the CDC Country Director in the Dominican Republic. Dr. Morgan was an Epidemic Intelligence Service Officer at CDC from 2007 to 2009 with the International Emerging Infections Program, during which time he conducted projects in Thailand, Bangladesh, Kenya, Uganda, and Guatemala. Before joining CDC, Dr. Morgan worked for the UK Health Protection Agency, leading epidemiological investigations of outbreaks (enteric, vaccine preventable, hospital acquired, zoonotic, respiratory, and sexually acquired infections), chemical and radiation exposure incidents, terrorist bombings in London, natural disasters, and humanitarian civil conflicts. Dr. Morgan has also worked as a consultant to WHO/PAHO in several countries. Dr. Morgan’s academic achievements include a doctorate in epidemiology from Imperial College London and extensive publication in peer reviewed journals and reference books.

Named one of the 40 most influential Healthcare Technology Transformers in 2017, Jenny is responsible for ensuring that all our neuroscience products and services meet the highest scientific standards, as well as the practical needs of researchers, doctors and patients.  Jenny joined Cambridge Cognition in 2008 and has worked in a variety of roles across the clinical trials and healthcare arms of the business. She led research and development activities for groundbreaking products such as CANTAB Mobile, an iPad-based medical device used to test for the first signs of Alzheimer’s disease, and Cognition Kit, a mobile and wearables platform for the remote monitoring of brain health.

Jenny has an MA in Experimental Psychology from Oxford University, a PhD in psychiatric epidemiology from the University of Cambridge, and completed post-doctoral work at Massachusetts General Hospital and the Broad Institute of Harvard and MIT. She is an Honorary Research Fellow at the University of Cambridge Department of Psychiatry, a team member of the Oulu University, Northern Finland Birth Cohorts, and the author of more than 50 academic publications covering topics ranging from psychology and neuroscience to genetics and health economics.

Clara Palau is the product manager for UNICEF’s Magic Box, an initiative focused on using data science and artificial intelligence to support humanitarian and development programmes for the most vulnerable children, by enabling partnerships through private sector, academia and public organisations.  

Before joining UNICEF, she gained international experience as a manager and as a researcher in different industries and technology areas, working for Orange, CERN and Indra. She holds a MsC in telecommunication engineering and a master in non-profit organisation management.

Steve Guise has been Global Head of Informatics for Roche Pharmaceuticals since October 2016. During these nearly two years, Steve has built and led a new informatics organization focused on business partnering and driving technology innovation to address business challenges — to ultimately benefit patients. 

Steve joined Roche in 2008 as Basel Site Head, Pharma Research Informatics. In 2010, he became Global Head of Scientific Information Systems and Principal Architect, Pharma Research and Early Development (pRED) Informatics. Steve was Head of Pharma Informatics for Asia Pacific based in Shanghai and Singapore for three years. He then took on the role of Head of Diagnostics Information Solutions Software Center of Excellence before being appointed Global Head of Informatics. 

Steve is passionate about finding new ways to more effectively bring medical innovation to our patients, particularly where the application of technology can bring about a step change.

Prior to joining Roche, Steve held various IT and management positions at Astra Zeneca in the UK. He has a Master’s degree in Chemistry from The University of St Andrews (UK). 

Allison lectures at Keele University in Bioinformatics and Data Science and is the Programme Director for the Data Science Degree Apprenticeship. She is a co-founder of Women Leading in AI. Her research is primarily focused on algorithmic bias; gender and computing; AI Ethics and Governance of AI. She works on the IEEE P7000 Global Initiative on the Ethics of Autonomous and Intelligent Systems and the ISO standard on Artificial Intelligence. She speaks internationally on AI Ethics, the need for diversity in tech and the potential regulation and governance of AI. Allison acts as a consultant for a variety of companies on the ethical design of autonomous and intelligent systems and development of algorithmic impact assessments. She is also a district councillor and an alumnus of the first cohort of the Jo Cox Women in Leadership Programme.

Andreas Cleve is Corti’s co-founder and CEO. After spending nearly a decade working as a multi-entrepreneur in AI, Andreas founded Corti. Corti uses advanced voice- and pattern recognition technology to assist and augment medical professionals in predicting medical cases in real-time and provides them with intelligent decision support. It allows them to arrive at a conclusion faster and
to provide a better-informed treatment.

Andreas has always been incredibly passionate about the possibilities that AI can provide to the healthcare sector and how we can leverage advanced technology in our most vital industry. While serving as CEO of Corti, he founded Nordic.AI and now sits as chairman of the board. Nordic.AI was created as an anchor for the Nordic machine learning and AI community, it hosts early events and meetups, bringing all the great Scandinavian minds together. Andreas has landed coverage
in print and broadcast outlets all

Dr Roopa Dhatt is a passionate advocate for gender equality in global health and a leading voice in the movement to correct the gender imbalance in global health leadership. Determined to build a movement to transform women’s leadership opportunities in health, Dr Dhatt co-founded Women in Global Health in 2015.

Today, Women in Global Health has more than 25,000 supporters in more than 90 countries and continues to grow. Dr Dhatt, the Executive Director, and the global team work with a network of WGH chapters in every region to challenge power and privilege for gender equity in health by mobilizing a diverse group of emerging women health leaders, by advocating to existing global health leaders to commit to transform their own institutions, and by holding these leaders to account.  With more than 15 chapters in all regions, Women in Global Health is changing the conversation about women’s leadership in health at global, national and local levels.

Dr Dhatt is particularly committed to addressing issues of power, privilege, and intersectionality that keep many women from global health leadership roles and to opening up spaces for the voices of these women to be heard. Women in Global Health’s flagship Heroines of Health event provides a platform for women from diverse backgrounds to share their stories and to advance their leadership. As Co-Chair of the Gender Equity Hub in the Global Health Workforce Network, Women in Global Health published Delivered by Women, Led by Men which looking collectively for the first time at issues of leadership, decent work free from all forms of discrimination, harassment, including sexual harassment, the gender pay gap, and occupational segregation—across the entire health workforce. In recognition of her work advancing gender equality in health, Dr Dhatt was recognized in the Gender Equality Top 100, the most influential people in global policy 2019.

Dr Dhatt is a regular speaker at global health events and has published her views on gender equality widely, including in the Lancet. Dr Dhatt also serves on several advisory bodies advancing gender equality in health, President Council of PathFinder International, Ambassador for Intelligent Health (AI) Conference, the Strategic Advisory Committee for the Global Health Workforce Network (GHWN), and GlobeMed Advisory Board. She was formerly on the Research in Gender and Ethics (RinGS) Advisory Board, Global Health 50/50 Advisory Council, the Global Health Council Advisory Council, and Women Leaders in Global Health Conference Steering Committee in 2017 and 2018. She has led global campaigns relating to the health Sustainable Development Goals (SDGs), health and climate change, the social determinants of health, and Universal Health Coverage (UHC), engaging people from more than 120 countries.

Marco Marsella is Head of Unit ‘Learning, Multilingualism and Accessibility’ in the Directorate General for Communications Networks, Content and Technology (DG CONNECT) of the European Commission.  

 The unit supports policy, research, innovation and deployment of learning technologies and key enabling digital language technologies and services to allow all European consumers and businesses to fully benefit from the Digital Single Market. The unit is responsible for the Web Accessibility Directive which aims to make public sector websites and mobile applications accessible to people with impairments. The unit also promotes a better internet for children by protecting and empowering children online, and improving the quality of content available to them.

 He has worked on policy development, innovation and research implementation in the areas of digital content, technologies for learning, e-inclusion, assistive technologies and better internet for kids. Prior to joining the European Commission, Marco worked as researcher and AI (artificial intelligence) specialist in Italy.

Thomas Wiegand is a professor in the department of Electrical Engineering and Computer Science at the Technical University of Berlin and is jointly heading the Fraunhofer Heinrich Hertz Institute, Berlin, Germany. He received the Dipl.-Ing. degree in Electrical Engineering from the Technical University of Hamburg-Harburg, Germany, in 1995 and the Dr.-Ing. degree from the University of Erlangen-Nuremberg, Germany, in 2000. 

The projects that he co-chaired for the development of the H.264/MPEG-AVC standard have been recognized by an ATAS Primetime Emmy Engineering Award. He was also a recipient of a ATAS Primetime Emmy Engineering Award for the development of H.265/MPEG-HEVC and a pair of NATAS Technology & Engineering Emmy Awards.

Amandeep Singh Gill joined the Indian Foreign Service in 1992.

He has served abroad at the Indian Mission to the UN and the Conference on Disarmament in Geneva (1994-1996, 2010-2013), the Indian Embassy in Tehran (2001-2004) and the High Commission of India in Colombo (2004-2006). At headquarters in New Delhi, he has served thrice in the Disarmament and International Security Affairs Division (1998-2001, 2006-2010 and 2013-2016) as well as in the United Nations Division (1996-1998). He served as the Head of the Disarmament and International Security Division in the Ministry of External Affairs from 2013 to 2016. He has also served as an expert on the UN Secretary General’s panels of experts on the Fissile Material Cut-off Treaty (FMCT), Small Arms and Light Weapons and on Missiles. He participated in the UN Disarmament Fellowship programme in 1999.

He is the current Chair of the Group of the Group of Governmental Experts (GGE) of the Convention on Certain Conventional Weapons (CCW) on Lethal Autonomous Weapons Systems (LAWS). He is also President-designate of the 2017 Meeting of States Parties to the Biological and Toxin Weapons Convention (BTWC).
Amandeep Singh Gill has a B. Tech in engineering from Punjab University, Chandigarh and an Advanced Diploma in French History and Language from Geneva University. His PhD from the Department of War Studies at King’s College, London is on Nuclear Learning in Multilateral Forums. During 2008-2009, he was a visiting scholar at Stanford University’s Center for International Security and Cooperation (CISAC) on an Asia Foundation regional security studies fellowship. As a scholar he has contributed to the Bulletin of Atomic Scientists, the Lowy Institute, the East West Institute, the Center for a New American Security and the Indian Economic and Social History Review.

Amandeep Singh Gill was born in 1968 in Chandigarh. He is married to Ashma Singh and has a daughter (Bani) and a son (Ujjay). His personal interests include creative writing, yoga and sustainable agriculture. His first book of poems in English was published by Wisdom Tree in 2016.

Dr. Anurag Agrawal took charge as director of CSIR Institute of Genomics & Integrative Biology (IGIB) on 25th October 2017. He graduated in medicine from the All India Institute of Medical Sciences in 1994, followed by specialization in Internal Medicine, Pulmonary Disease, and Critical Care from Baylor College of Medicine, Houston, (2003) and a PhD in physiology from Delhi University. After serving as a faculty member of the Department of Medicine at Baylor, he joined IGIB in 2007, where he established the Centre of Excellence for Translational Research in Asthma & Lung disease (TRiAL) and the CSIR program for Effective Application of Community Health efforts through new age Information Technology (EACH-IT). His research activities include use of experimental and computational model-systems to study disease, especially asthma. Dr Agrawal believes health data analytics, with artificial intelligence applications, to be the new frontier of medicine and is actively engaged in promoting the confluence of medicine and informatics. He has more than 100 scientific publications, mostly original research findings communicated in high-impact journals. He has been recognized internationally, as an alumnus of Kavli Frontiers of Science program of the US National Academy of Sciences, as well as nationally in the form of the Shanti Swaroop Bhatnagar award (Medical Sciences, 2014), National Bioscience award (2015), Wellcome Trust DBT India Alliance senior fellowship (2015), Lady Tata Young Researcher Award (2010) and the Swarnjayanti Fellowship of the Department of Science and Technology (2010). Dr. Agrawal is a member and fellow of numerous academic societies and serves on advisory bodies at Public Health Foundation of India, Lady Tata Memorial Trust, Centre for Cellular & Molecular Biology, Centre for Brain Research, and Indraprastha Institute of Information Technology, amongst others, as well as an advisor for start up companies and healthcare organizations.

Eric Karl Oermann, M.D. is an Instructor of Neurological Surgery in the Mount Sinai Health System and the Director of AISINAI, Mount Sinai’s artificial intelligence research group. He studied mathematics at Georgetown University with a focus on differential geometry. Prior to attending medical school, Dr. Oermann spent six months with the President’s Council on Bioethics studying human dignity under the mentorship of physician-philosopher Edmund Pellegrino, M.D.. Dr. Oermann has won numerous awards for his scholarship including fellowships from the American Brain Tumor Association and Doris Duke Charitable Research Foundation where he was first exposed to neural networks and deep learning. He has published over eighty manuscripts spanning basic research on machine learning, deep learning, and the philosophy of medicine.

As a resident Dr. Oermann was selected as one of Forbes Magazine’s “30 Under 30” for his work in using machine learning to develop prognostic models for cancer patients. Dr. Oermann completed a postdoctoral fellowship at Google (Google Health / Verily Life Sciences). He is interested in weakly supervised learning, reinforcement learning with imperfect information, and in building artificial neural networks that more accurately model biological neural networks (“machines that think like humans”). As a physician, he is also interested in the application of deep learning to solve a wide range of practical problems in the medical sciences for improving clinical care.

Dr. James Kinross is a consultant colorectal surgeon, at St. Mary’s Hospital London. His clinical interests are in minimally invasive and laparoscopic surgery for the treatment of colorectal cancer. He also has an interest in surgical nutrition and modulation of the gut microbiota by pro and prebiotics for improved operative outcomes. He was trained in Northwest London, and he was an NIHR Clinical Lecturer in Surgery and an Ethicon Laparoscopic Fellow in Colorectal Surgery. He was awarded a Royal College of Surgeons of England training fellowship during his PhD and he was funded by the Academy of Medical Sciences as an early stage lecturer. He is a visiting Professor at the Royal College of Surgeons of Ireland. He is currently funded by Bowel and Cancer research and the Imperial BRC. You can follow him on Twitter at @bowelsurgeon. 

He performs translational research into computational and systems biology in surgery. Specifically, he is involved in clinical trials using intra-operative mass spectrometry (known as Real-time Electrospray Ionisation Mass Spectrometry or REIMS) for improving precision in the surgical treatment of colorectal cancer. This technology is also known as the iknife, and he is working on both surgical and endoscopic applications. Mass Spectrometry Imaging (MSI) is complimentary to REIMS and provides novel insights into tumour biology and tumour phenotypes. Dr. Kinross’s research is establishing if metabonomic approaches such as these can be used for stratifying the treatment of both early and advanced cancers. 

Dr. Kinross also studies the role of the gut microbiome in the aetiology of colon cancer, Crohn’s disease and obesity. This is because intestinal inflammation is a common pathway across all conditions. He is performing clinical research at Imperial College London and at the Royal Marsden Hospital. The aim is to develop novel biomarkers for the early detection of bowel cancer, and to develop novel therapies for its treatment based on a deeper understanding of how the microbiota that reside in the gut influence tumour biology and the response of cancer to treatment. As part of this I collaborate internationally with researchers in the USA and across Europe.

Finally, he has a separate interest in the educational application of virtual worlds and gaming technologies for surgical and medical education. He works as part of a team that is building next generation, immersive simulators for use in major incidents and trauma training.

Oliver Smith is the Strategy Director & Head of Ethics at Alpha Health, the health tech Moonshot of Telefónica Innovación Alpha.

Oliver propels Alpha Health’s strategy development, establishing and maintaining strong partnerships to further its mission to deliver breakthrough solutions which address the greatest challenges in the healthcare sector worldwide. In addition, Oliver is the Head of Ethics at Alpha Health, ensuring the total trust of users is at the very centre of the Moonshot’s operations.

Prior to joining Alpha Health in 2016, Oliver worked as the Director of Strategy and Innovation at Guy’s and St Thomas’ Charity, Deputy Director of Health and Wellbeing at the Department of Health and as a Policy Advisor to the Prime Minister’s Strategy Unit.

Dr. Amrita Kumar is a Consultant Radiologist at Frimley Health NHS Foundation Trust, with a sub-specialist interest in breast cancer screening. She is leading trust wide research collaboration to implement novel artificial intelligence software for improved patient outcomes. She has been appointed as AI Clinical Lead and is responsible for implementation and adoption of Artificial Intelligence practice within the Trust, working in conjunction with various stakeholders with a mission statement of patient-focused value-based healthcare.

Victoria Macdonald is an award-winning journalist, who has been covering health and social care issues for Channel 4 News since 1999.

She reports on changes in the NHS – the reforms and the politics – whether it is in hospitals or in the community or, indeed in Westminster.

She closely follows the care system and how it impacts on the elderly and those with disabilities as well as investigating issues, including mental health, HIV/Aids and TB, and child health.

Victoria is originally from New Zealand and worked for the Sunday Telegraph before joining Channel 4 News.

Dr Sujoy Kar is the Chief Medical Information Officer & Vice President at Apollo Hospitals. Previously, he was the Director Medical Services at Apollo Gleneagles Hospitals Kolkata. He obtained his post graduate MD in Clinical Microbiology & Infectious Diseases and is an alumnus of MIT Sloan School of Management. He is a Certified Six Sigma Master Black Belt (Indian Statistical Institute) and member of professional organisations like ACHE, VRARA (Member – Healthcare Sub Committee), CHIME, Harvard Square (LE), ICMR – CIBioD (Member Task Force) and World Economic Forum – Chatbot & AI in Healthcare.

Dr Sujoy is currently associated with IIT Kharagpur & IIM Calcutta as Adjunct Faculty for Healthcare Analytics and Management. He has led teams in multiple award winning Patient Safety & Process Improvement projects. His current and ongoing research interests are in adoption of Artificial Intelligence & Blockchain Technology in Healthcare, Time Driven Activity Based Costing, Living Labs, Digital Health Platforms and Design Thinking in Healthcare.

Sue is the CEO of Canada’s Digital Supercluster where organizations from across
Canada come together to solve some of society’s and industry’s biggest problems.
Bringing together industry, researchers and government partners, the Supercluster
drives the development, deployment and scaling of Canadian made digital technologies
while helping small companies scale, large organizations nimbly deploy digital solutions
and researchers bridge the gap to commercialization. The Supercluster is: speeding up
cancer diagnosis times so that patients get diagnoses in days rather than months,
protecting fresh-water lakes, rivers and streams through a data platform that measures
and manages these precious resources, and using data to predict extreme weather
events. These are just a few of the over 60 projects deployed in the past two years.
Prior to the Supercluster, Sue led organizations through material change. While
Managing Partner of Fasken, the firm grew from one office to nine offices on three
continents, while CEO of Pharmasave, the organization pioneered industry leading
technologies for online medication management, and while CEO of LifeLabs, Sue led
material growth while introducing online access to test results and pre-natal genetic
testing. With the Supercluster, Sue continues to drive business growth and Canada’s
global competitiveness through the Supercluster’s collaborative innovation model,
creating digital solutions better than any single organization could develop on its own.
Sue also is the Chair of the Board of CORIX Group of Companies, and Canexia Health
(previously Contextual Genomics), past Chair of the Business Council of British
Columbia and a Director on the Board of Own the Podium. She is a member of the
Advisory Board for Stemcell Technologies, the Expert Panel on Housing Supply and
Affordability and the Government of Canada’s COVID 19 Supply Council.
Sue’s most cherished moments are those spent exploring BC’s remarkable remote
wilderness with her husband, three daughters and her granddaughter.

Dr. Dagher is an M.D./Ph.D. who studied Electrical Engineering and Medicine. He is a Neurologist and Professor at McGill University in Montreal (clinician and scientist). His research aims to understand brain reward systems and their role in neurological and psychiatric illness.

He uses brain imaging, notably functional magnetic resonance imaging (fMRI), to map brain activity in response to drugs or natural rewards like food and music. He is particularly interested in figuring out what in the brain makes individuals vulnerable to mental illness. He splits his professional life between clinical neurology and research and teaching. He sees people with Parkinson’s Disease in his clinic once a week. Dr. Dagher teaches medical students and Ph.D. students in neuroscience.

Dr Indra Joshi is the acting Director of AI for NHSX, leading on the creation of the NHS AI Lab. Her other responsibilities include overseeing digital health initiatives within the NHS with a focus on data, digital health standards and evidence.

Indra has a unique portfolio with experience stretching across policy, digital health, national project strategy and implementation; whilst remaining true to her professional training as an emergency medic.

She is a Founding Member of One HealthTech – a network which campaigns for the need and importance of better inclusion of all backgrounds, skill sets and disciplines in health technology. Alongside she is a Vice-Chair for the British Computer Society (Health), an international speaker and consultant on digital health, an expedition medic, and most importantly a mum to two wonderful little munchkins.

Andrea Superti-Furga has obtained his medical degrees at the Universities of Genoa and Zurich and certification in Paediatrics in Italy and Switzerland. His mentors were Professors Paolo Durand, Victor McKusick, Andrea Prader, Andres Giedion, Richard Gitzelmann, Beat Steinmann and Sergio Fanconi.

He developed a research activity on inborn diseases in Zurich and then in New York with Prof. Francesco Ramirez. In 2002, he was appointed Professor for Molecular Pediatrics at the University of Lausanne; in 2004, Chairman of the Department of Paediatrics at the University of Freiburg, Germany; in October 2010 he was awarded the Leenaards Chair of Excellence in Paediatrics at the University of Lausanne. In 2014 and 2015 he was Director of the Department of Paediatrics in Lausanne. Since 2016 he is Professor and Head of the Division of Genetic Medicine at the University Hospital in Lausanne, Switzerland, that includes a clinical section as well as a diagnostic laboratory for cytogenetics and molecular genetics.

His clinical expertise is in paediatrics and genetics. His research activities have been focussed mainly on genetic disorders affecting metabolism, connective tissue, and the skeleton. His skills range from clinical assessment and evaluation to biochemistry, metabolism, molecular biology, next-generation sequencing, bioinformatics, and artificial intelligence.

Andrea Superti-Furga is committed to a holistic approach to children and adults with genetic disorders and rare diseases with a comprehensive perspective that includes the genetic and molecular bases of development and disease, the precision medicine approach to diagnosis and treatment, and the medical, social, economical and ethical issues around individuals with genetic diseases and their families.